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In rats, unilateral lesions in the ventro-medial area of the crus
cerebri, where the striato-nigral pathway runs, produced a significant
decrease in the concentration of substance-P, Gamma-amino-butyric-acid
and glutamic-acid-decarboxylase activity in the substantia nigra
ipsilateral to the lesioned side. The striato-nigral pathway has been
proposed to mediate the effects produced by the systemic administration
of dopaminergic agonists, (e.g. apomorphine or amphetamine) and
antagonists (e.g. haloperidol) on dopamine metabolism in nigral cells.
However, the lesions reported here do not alter the concentration of
dopamine or its metabolites homova]{inic-acid and dihydroxyphenylacetic
acid in the striatum, in comparison with control animals, even after the
administration of haloperidol and apomorphine. Recordings of
dopaminergic nigral cells in rats with chronic and acute electrolytic
lesions in the crus cerebri or with kainic acid lesions in the
striatum, did not differ from recordings done in control animals. An
intravenous administration of amphetamine, significantly reduced the
firing rate of dopamine nigral cells in both control and lesioned
animals. Similarly, haloperidol blocked the effect of a subsequent
administration of amphetamine in both groups. The only lesions which
effectively abolished the inhibition of nigral cell activity after
amphetamine injections were those which destroyed some of the dopamine
cells. These results are discussed as evidence for an alternative
mechanism responsible for the observed inhibition which could also be
involved in the regulation of dopamine metabolism. A behavio'ral study
shows that lesions in the striato-nigral pathway induced after
apomorphine a dosS-dependent turning towards the lesioned side and
significantly/
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significantly decreased the number of turns induced in a
6-hydroxydopamine lesioned animal after apomorphine. Rats also
changed their paw preference during lever pressing after a crus cerebri
T
lesion contralateral to the prefehed paw. A possible function for the
striato-nigral pathway in the expression of motor behaviour is
discussed.
GENERAL INTRODUCTION.
In 1963, Arvid Carlsson (48), while investigating the effects of
antipsychotic drugs, (neuroleptics) on dopamine turnover in the
striatum, proposed a feedback loop (substantia nigra-striatum-
substantia nigra) suggesting an important role for the striato-nigral
pathway in the control of dopamine metabolism. It was proposed that
by means of this loop, dopaminergic transmission in the striatum results
in decreased activity in dopaminergic neurons, while blockade of
dopaminergic transmission in the striatum produces increased activity
in dopaminergic neurons in the substantia nigra. Since this hypothesis
was proposed, evidence in its favour has accumulated. A large number
of reports using different techniques suggest that antipsychotic drugs
and dopaminergic agonists exert opposite effects on dopamine turnover,
(238, 11* 61, 218). Further support for this hypothesis came from
evidence that systemic administration of dopaminergic agonists produces
a marked inhibition of neuronal firing of dopamine cells in the substantia
nigra while antipsychotic drugs reversed the effect of dopaminergic
agonists, (2, 41, l)• This coincided with the postulation that
amphetamine does not change dopamine metabolism because the feedback
compensated the drug induced release, (48). A finding that fitted into
this idea of feedback regulation was that gamma-amino-butyric-acid
(GABA), postulated as an inhibitory transmitter in the nervous system,
(252), was found in the substantia nigra, (226). Even more, GABA was
decreased in this area after a hemisection between the substantia nigra
and the strit_jum, (200) or striatal lesion, (278). This was taken as
evidence to support the idea that antipsychotic drugs inhibited GABA
containing neurons in the striatum which send their axons to the
substantia/
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substantia nigra. Antipsychotic drugs were postulated to decrease the
amounts of GABA in the substantia nigra, disinhibiting dopamine neurons
and in turn increasing dopamine synthesis, (l35). An anatomical and
biochemical analysis of the distribution of the activity of the
synthetic enzyme of GABAo glutamic acid decarboxylase, (GAD) in the
substantia nigra of cats, indicated that the loss of enzyme activity was
localized and related to the site of termination of the degenerating
striato-nigral fibres, (ill). These results left the striato-nigral
pathway as a GABA containing one and the most likely for the
proposed feedback.
However, not all the evidence has been in favour of the hypothesis
of feedback regulation. For instance, iontophoretic administration of
dopamine into substantia nigral cells, reduce their firing rate (39,4l)
as it does in the striatum, (l02, 303), suggesting that substantia
nigral cells are also responding to their own transmitter. Also,
release of dopamine within the substantia nigra has been observed in
studies using in vitro and in vivo methods, (32, 217). This has
suggested the possibility of alternative mechanisms to explain the
effect of dopamine agonists and antipsychotic drugs in the metabolism
of dopamine. In particular, it has been proposed that the blockade of
dopamine receptors in the substantia nigra could relieve dopamine
neurons from the inhibitory action of dopamine released within the
substantia nigra, possibly by dendrites or axon collaterals of the same
dopamine cells, (119).
A way of testing whether this local control of dopamine neurons is
in fact operating or if the metabolism of dopamine is rather mediated
by striatal neurons, is to study the effect of dopaminergic agonists
and/
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and antipsychotic drugs on animals whose main striatal influence is
interrupted. So far, attempts to lesion the striato-nigral pathway
(200, 40,.130) are open to criticism because the lesion has not been
localized. Since the nigro-striatal and the striato-nigral pathways
run close together, if the lesion is not small and circumscribed there
is a high probability of damage to the nigro-striatal fibres and even
of nigral cells. Based on the anatomical tracing studies of the
striato-nigral pathway done in our laboratory by Tulloch et al (282),
evidence is presented of lesions of the striato-nigral pathway which
do not affect the nigro-striatal bundle. With these lesions, it was
possible t> study the effects of drugs which alter dopamine metabolism,
on animals which did not have the possible control exerted by the
striatum on dopamine cells proposed by the feedback hypothesis. The
results obtained with this technique point out that the idea of a
feedback loop has resulted in an oversimplification and that alternative
mechanisms for the control of dopamine metabolism must be considered.
The first Chapter gives a critical review of the most relevant
experiments in favour of or against the feedback hypothesis. The rest
of the work presents biochemical, electrophysiological and behavioural
evidence that suggests that the idea of a feedback loop is not
sufficient to explain the control of dopamine metabolism. Other
possible mechanisms to explain this control are discussed, as well as
the possible function for a pathway which can no longer be considered
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It is now 15 years since Carlsson and Lindqvist, (48) postulated
that if chlorpromazine and haloperidol block monoaminergic receptors
then: "... it does not seem unreasonable to assume that this receptor
blockade results in compensatory activation of monoaminergic neurons.
This activvation 'leading to increased release of monoamines and
consquently to increased formation of monoamine metabolites...",
(pag. 14l).
Since then, many investigators using different techniques, have
obtained evidence in favour of or against this hypothesis. For
instance, anatomical results confirm that there are fibres
interconnecting the nuclei. The feedback hypothesis has its origins
in biochemistry, and strong evidence in its favour has been obtained
from this area, although there are also experiments which give evidence
against it. Several alternative explanations to the feedback hypothesis
have been proposed, but none of them at the moment is completely
satisfactory. Electrophysiological experiments have demonstrated
the effect of several drugs on the activity of the cells in the
substantia nigra and the striatum, as well as their response to the
stimulation of the other nucleus. Hot all the results obtained in
this area agree with the feedback hypothesis and some results support
the alternative models proposed by the biochemists. If the results
obtained by anatomical, biochemical and electrophysiological techniques
are regarded as a whole, the picture is confused. Not all the evidence
agreeswith the hypothesis and furthermore the evidence against it
although/
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although strong enough to put the feedback idea in doubt, does not give
an alternative interpretation. In this Chapter an effort is made to
examine most of these results, as well as the alternative models.
1. ANATOMICAL EVIDENCE.
One of the strongest evidence in favour of the feedback pathway
has been the demonstration of the connections from the striatum to the
substantia nigra, and from the substantia nigra to the striatum,
without which the proposed hypothesis could not have been substantiated.
One of the first descriptions of the human substantia nigra was
made by Vicq d'Azyr in 1786, (29l) and it was described later in the
rat by Bauer, (2l) among others. The substantia nigra derives its
name from the melanin pigment in its cells, which gives a dark colour
to the nucleus in unstained sections. Melanin, however, is not
present in some animals like the laboratory albino rat, (77). This
nucleus lies in the mesencephalon above the cerebral peduncle on each
side. It is classically divided in three areas: lateral, compacta
and reticulata, (77). The lateral area is considered the oldest
phylogenetically and is the smallest portion of the region in man.
The pars compacta contains more numerous cells distributed close
together, this is the area which contains dopaminergic cell bodies.
In the pars reticulata the cells are sparse and this part of the
substantia nigra, like the pallidum and the red nucleus contains iron,
particularly in glial cells, (36). In rats, cells in the substantia
nigra do not seem to have a particular shape and in general measure
from 11-74 ^um; in ^he Pars compacta cells of 19 ^un predominate,
(156,136).
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1A. THE STRIATO-NIGRAL AND PALLIDO-NIGRAL PATHWAYS.
It seems that in humans, monkeys, cats and rats, the biggest
afferent connection to substantia nigra comes from the striatum,
(276,; 272, 273, 274, 259, 293, 168). Eibres leave the striatum in
the internal capsule, travel through the globus pallidum giving a
great number of fibres to this nucleus, and continue in the internal
capsule until they enter the substantia nigra pars reticulata, by
traversing the cerebral peduncle in a comb bundle, (293, 259)•
In primates and cats, (not in the rat), it is possible to divide
the striatum into caudate nucleus and putamen. Efferents from these
regions seem to project with a topographical organization, although
the details of its distribution are sometimes contradictory, (43, 273).
Szabo, (276, 275, 273, 274, 277) using anterograde degeneration
techniques, reported that the lateral areas of the caudate nucleus
project mainly to the external segment of the globus pallidum, and the
most medial caudate region mainly to the internal segment (cat's
entopeduncular nucleus). The caudato nigral fibres end in the
substantia nigra reticulata with a similar medio-lateral, and anterio¬
posterior distribution pattern. The tail of the caudate nucleus seems
to send fibres to the lateral area of the substantia nigra reticulata.
The anterior putamen appears to project almost exclusively to the globus
pallidus, while the rest projects to both the globus pallidus and the
posterior substantia nigra reticulata.
The evidence supporting the existence of pallido-nigral fibres
is conflicting, (247, 154) probably because lesions in the globus
pallidus damage afferent fibres from substantia nigra, which could
confuse/
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confuse the results. This connection was denied for sometime (247,
290) but was later confirmed in cats and monkeys (l54, 212) using
different staining techniques. Lesions in the medial globus pallidus
in monkeys or in the intopeduncular nucleus in cats showed degeneration
in the substantia nigra pars compacta (212).
The techniques using axonal degeneration give contradictory
results probably because the localization and size of the lesions
change. These techniques have some inherent problems, which make
interpretation of the results even more uncertain; for example, the
unspecific damage produced by the lesions, making it difficult to
interprete which is anterograde, which retrograde and which is
trans-synaptic, degeneration.
Many neuronal constituents synthesized in the cell body are
transported down the axon to reach the terminals, (230, 182). Also
proteins can be taken up by terminals and subsequently transported to
the cell body, (l79, 178). These two processes of anterograde and
retrograde transport have been used recently to trace afferent and
efferent pathways in the brain, (l24, 298).
An autoradiographic method takes advantage of the anterograde
transport. When a labeled protein precursor, like the tritiated amino-
acid leucine, is injected directly into a nucleus it is taken up by the
cell bodies at the site of the injection (but not by the axons that
have cell bodies elsewhere), and is transported to the terminals which
can then be identified by means of the effect of the emitted radiation
on photographic emulsions, (72).
The retrograde transport of proteins is used to trace afferent
pathways in the nervous system, (185, 213) by injecting mainly
horseradish/
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horseradish peroxidase and looking afterwards for a stained reaction
product of the peroxidase in the cells»
Using these techniques efferent fibres from the striatum and
afferents to substantia nigra have been traced. In cats and rats
(128, 140, 43) it has been observed that the striatum sends fibres
through the internal capsule to the globus pallidus and substantia
nigra. The globus pallidus, in turn, sends fibres to the substantia
nigra, although there is disagreement about the area (compacta or
reticulata) that this nucleus innervates, (43, 140).
The topographical projection of the striatum to substantia nigra
has been described in the rat using the retrograde transport of
horseradish peroxidase (43) reporting similar results to the ones Szabo
(.273) described previously, although they do not agree about the
antero-posterior arrangement of the efferents, from the tail of the
striatum, even though they agree that these efferents project mainly
to the lateral substantia nigra.
In our laboratory, Tulloch (282) using anterograde and retrograde
transport techniques, confirmed that the striatum and globus pallidus
project to substantia nigra reticulata. In agreement with previous
reports (140, 212), it was found that the globus pallidum projections
include the substantia nigra pars compacta. The tail of the striatum
was found to send fibres mainly to substantia nigra pars lateralis.
Previously it was suggested that in the cat only of caudate
cells send their axons to distal places, (l67), but in the rat using
the horseradish peroxidase method 30-50^ of the cells were labelled, all
of them being medium size cells (l2-20um), (43, 128, 167).
One/
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One of the problems of the horseradish peroxidase technique is
that it is uncertain whether or not damaged axons take up and transport
proteins, retrogradely (213, 30l). If they do, then one has to be very
cautious about interpreting the results and probably only take into
account those that prove to be consistent by various techniques.
IB. THE NIGRO-STRIATAL PATHWAY.
Attempts to trace nigro-striatal fibres by anterograde
degeneration were controversial in the early reports although they have
been consistently seen using retrograde degeneration methods, (99, 22).
With the use of silver impregnation techniques that stain fine fibres
and nerve terminals, it was possible to observe degeneration in monkeys,
cats and rats in the striatum after substantia nigra compacta lesions,
(55, 143, 209).
Formaldehyde condenses with the monoamines to form fluorophores
which can be observed in the cells by fluorescence microscopy. The
Falck and Hillarp technique (96) based on this principle has a high
degree of sensitivity because it is based on a fluorescence reaction and
not on a conventional staining procedure.
Using this technique, it was demonstrated that there are dopamine
containing neurons in the substantia nigra compacta which send their
axons to the striatum (4)0
As expected, injections of horseradish peroxidase into the striatum
labeled presumed dopamine-containing neurons in the substantia nigra
compacta, (l79)~
Using different anatomical techniques, it is consistently found
that the substantia nigra projects in a topographical arrangement to
the/
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the striatum, in monkeys, (285, 57, 55). Posterior and lateral areas
of the substantia nigra project to posterior and lateral areas of the
striatum; there is a disagreement as to whether the antero-medial
substantia nigra projects to most of the striatum, (285) or only to the
anterior areas, (55, 22).
From earlier studies it was thought that the fibres leaving the
substantia nigra compacta joined the internal capsule to ascend to the
striatum, (55, 4), however it was later demonstrated that first the
axons accumulate medial to the substantia nigra coinciding with the
medial forebrain bundle in the lateral part of the hypothalamus, before
entering the internal capsule, (232, 22). In order to arrive at the
striatum the fibres cross the globus pallidum, making it difficult to
corroborate the existance of a nigro-pallidal projection, (22).
1C. PREVAILING INTERPRETATIONS.
These two pathways reciprocally connecting the striatum and the
substantia nigra, give a basis for the idea of a "compensatory feedback
mechanism". The turnover of dopamine according to this idea, depends
on the activity of dopaminergic cells in the substantia nigra which are
controlled by afferent fibres coming from the striatum. However, against
this idea of feedback it can be argued that if dopamine containing cells
projecting to the striatum are confined in the substantia nigra pars
compacta, how is it that fibres coming from the striatum, ending in
substantia nigra pars reticulata, exert a control over substantia nigra
pars compacta cells? To keep the system connected, alternative
explanations may be'brought into play. Interneurons have been
observed in substantia nigra, (264), which could close the feedback
loop./
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loop. Also numerous dendrites from cells in the pars compacta invade
the zona reticulata, (264, 73) and axo-dendritic synapses could complete
the system. There is also the possibility that fibres from the tail
of the striatum or from globus pallidum, if ending in substantia
nigra pars compacta, (l40, 212, 282). could be involved in the mechanism
of feedback control.
In general, the anatomy supports the idea of a reciprocal relation
between substantia nigra and the striatum which may be considered as
the basis for a feedback mechanism.
2. PHARMACOLOOICAL MP BIOCHEMICAL EVIDENCE.
The whole idea of a "compensatory feedback mechanism" was
proposed to explain the effects of dopaminergic receptor blocking
agents like haloperidol, chlorpromazine and other antipsychotic drugs,
(neuroleptics).
These drugs have been shown to enhance the dopamine turnover in
the striatum (Section 2k), and as postulated, block dopamine receptors
and influence a negative feedback mechanism leading to activation of
dopaminergic neurons, (48).
2k. EVIDENCE IN FAVOUR
Al. EFFECT OF DOPAMINE RECEPTOR AGONIST OR ANTAGONIST Oh DOPAMINE
TURNOVER.
A large number of reports suggest that the antipsychotic drugs
increase dopamine turnover and to a lesser extent the turnover of
norepinephrine,/
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norepinephrine, (223, 225). Different catecholamine metabolites, like
normetanephrine, 3-methoxytyramine (48), and 4-hydroxy-3-methoxy-
phenylacetic acid, (HomovaHinic acid, HVA), (238) and
dihydroxypheny.lacetic acid (Dopac), (254), are found to be increased
after antipsychotic drugs.
If the synthesis of dopamine is blocked by inhibiting the enzyme
that converts tyrosine into Dopa, tyrosine hydroxylase, with alpha
methyl-para-tyrosine, (.AMPT), the concentration of dopamine in the
striatum is reduced, (69). By giving antipsychotics like haloperidol
or chlorpromazine (ll) the rate of disappearance of dopamine is
increased, which also indicates that dopamine synthesis is enhanced
after these drugs.
Apomorphine, a dopaminergic agonist (6, 93), causes opposite
effects to those produced by antipsychotic drugs. For example, it
caused a significant decrease in HVA in the striatum, (253); after
AMPT, apomorphine decreases the rate of dopamine disappearance (ll).
After inhibition of Dopa decarboxylase (the enzyme that converts Dopa
into dopamine), the accumulation of Dopa is markedly inhibited, by
apomorphine, (l66).
The fact that the blockade or stimulation of dopamine receptors
have oppQsite effects led to the conclusion that the feedback
originates from the postsynaptic dopamine receptor activity.
Another method used to detect changes in catecholamine synthesis
is the measuring of the accumulation of labelled dopamine formed from
radioactive tyrosine (L-3,5- H tyrosine, (6l) or "^C tyrosine, (225), or
the accumulation of tritiated water formed during the conversion of
tritiated tyrosine into Dopa (l23).
The/
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The labelled tyrosine has been administered intravenously (6l), by
local microinjection (6l) or by local superfusion from a cup placed at
the surface of the caudate nucleus (118) or from a push-pull cannula
inserted into the nucleus, (213). The way in which it is administered
also changes the way in which the radioactive product is collected.
However, despite the possible differences, advantages or disadvantages
of the methods, the results are consistent. After antipsychotic
drugs, the dopamine synthesis is increased (61, 123, 225, 223, 218).
A2. IMPULSE -FLOW AMD DOPAMINE TURNOVER.
The effect of chlor 'promazine on the accumulation and disappearance
14
of dopamine formed from C-tyrosine in different rat brain regions,
(221, 222), indicated that the effect was confined to the striatum.
Therefore it was thought, in accordance with the feedback hypothesis,
that the effect of antipsychotic drugs may be induced by accelerating
nerve impulse activity in the nigro-striatal pathway.
In support of this idea, it was shown that chlor promazine had
no significant effect after the interruption of the nigro-striatal
dopamine pathway, (225) and the disappearance of dopamine after AMPT
was counteracted by a nigral lesion, (8)» Thus suggesting that impulse
flow was necessary for the antipsychotic drug induced increase in
dopamine turnover.
Further evidence that gave support to the idea that increased
impulse flow in dopamine cells was responsible for the increase in
dopamine synthesis after dopamine receptor blockade came with the
experiments on gamma-aminobutyric acid, (GABA) a known inhibitory
transmitter (252) which was found in one of the highest concentrations
W
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in the substantia nigra (226, 278). Hemisection (200) or lesions in
the striatum (l69, 200) produced a marked decrease in GABA and its
synthetic enzyme, glutamate decarboxylase (GAD, (278, 279). This
suggested that antipsychotic drugs blocked dopamine receptors on GABA
containing neurons in the striatum producing a decrease in GABA in
the substantia nigra, with a consequent release of the dopamine cells
from inhibition resulting in an increased impulse flow and dopamine
synthesis. In support of this idea, it was shown that Muscimol,
(GABA agonist) injected directly into substantia nigra concommitantly
with a systemic injection of haloperidol reduced the haloperidol
induced activation of TOH in the striatum by 50/>, (l35). According to
this, antipsychotic drugs activate dopamine neurons and increase
striatal TOH by causing a reduction in the release of GABA (as
inhibitory transmitter) from the terminals of the striato-nigral
pathway, (l35). However, it has been shown that haloperidol produces
an increase in the concentration of GABA (after GABA transaminase
inhibition) in substantia nigra, (58). Therefore if GABA is
considered as an inhibitory transmitter over dopamine cell bodies,
then the increase in GABA accumulation after haloperidol cannot be
directly correlated with the increase in dopamine turnover as a result
of an increase in impulse flow.
2B. EVIDENCE AGAINST.
Bl. IN VITRO STUDIES.
When the effects of systemic or intracerebral administration of
drugs are estimated using intact brains, all sorts of interactions
between structures can be proposed. The problem begins when these
relations/
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relations are maintained after sectioning the brain.
In vitro treatment of the rat striatal slices with neuroleptics,,
increased labelled dopamine over flow in response to field stimulation,
(98, 97). Therefore the effects induced in vivo by different processes,
can still be detected in vitro when the feedback cannot operate anymore.
While it cannot be excluded with this evidence that the feedback
does exert any effect, it seems at least as likely that another kind
of mechanism is also involved in the regulation of dopamine metabolism.
B2. PRESYNAPTIC RECEPTORS.
As was previously mentioned (section A2) there is evidence that
nerve impulse flow is correlated with the synthesis of dopamine and the
effects of antipsychotic drugs, (8). However, when the nigro-striatal
fibres are interrupted, the synthesis in the terminal fibre system is
not inhibited, but instead is stimulated, (l66).
Interruption of impulse flow by electrothermic lesions, mechanical
transection, or injection of local anaesthetics, (l66, 164, 296),
produces a marked increase in dopamine levels in the striatum.
With the impulse flow non-existent in these preparations the
effects of neuronal feedback loop are eliminated and any drug induced
alterations must be mediated by another mechanism.
It has been shown that apomorphine prevents the increase in
dopamine levels, (l64, 296) induced by cessation of impulse flow and
that the increase is restored by a combined treatment with haloperidol
and apomorphine. Therefore it was proposed that the effect is
mediated by a presynaptic dopamine receptor, (ll).
B2.l/
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B2.1 TYROSINE HYDROXYLASE ACTIVITY.
The accumulation of Dopa after the inhibition of dopa-decarboxylase
is considered as an index of the activity of (TOH) tyrosine hydroxylase,
(11).
Since after the axotomy of the nigrostriatal fibres, the
accumulation of dopa is increased, it was concluded that the activity of
TOH is enhanced.
The control of TOH cannot be exerted in this case by end product
inhibition since according to this idea, when there is a decreased
impulse flow and less transmitter is used, the synthesis should be
slowed.
Thus the dopamine system appears to respond differently when
compared to other monoamine systems, (ll)» In particular, an
inhibition of impulse flow causes a rapid increase in the transmitter
contents of its terminals. In similar conditions, the synthesis of
norepinephrine for instance does not increase, (ll, 49, 177).
When the nigro-striatal fibres are stimulated there is a stimulus
dependent increase in the accumulation of Dopa, (255). And this
increase in TOH activity persists for about 15 minutes after cessation
of stimulus.
The kinetics of the enzyme are also affected; after stimulation,
there is an increase in the affinity of TOH for the pterin cofactor
(BH^j an electron donor), and an decrease in the affinity for the end
product inhibitor, dopamine, (256).
Therefore, in these conditions the enzyme is more active to
produce more Dopa and at the same time less liable to be inhibited by
dopamine/
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dopamine if it accumihLtes.
After impulse flow inhibition, there is also an increase in TOH
activity, but the kinetics of the enzyme are different from those
after stimulation. TOH has a marked increase in its affinity for
tyrosine and pterin cofactor and a marked decrease in its affinity
for dopamine. Therefore, in this case, although the enzyme is more
active and produces more Dopa, it is not inhibited by its end product
causing an increase in dopamine.
Thus it appears that a blockade of impulse flow leads to a change
in the physical properties of the enzyme molecules; the problem is to
know the mechanism responsible for this change.
A possible mechanism has been proposed based on the idea that adenyl
cyclase could be the dopamine receptor.
B2.2 ADEUYL CYCLASE AS THE DOPAMINE RECEPTOR.
This enzyme forms cyclic adenosine monophosphate (cAMP) from
adenosine triphosphate, (ATP).
It was first observed that dopamine, which was known to hyperpol-
arize the post ganglionic neurons of the superior cervical ganglion also
caused an increase in ganglionic cAMP (l98). Moreover it was found
that cAMP is able to mimic the hyperpolarizing action of dopamine, (l99).
Using homogenates of the ganglion, it was shown that dopamine
stimulated the adenyl cyclase, (l62). This occurred at very low
concentrations of dopamine, suggesting that the effect was specific,
(l62, 126). Homogenates of rat striatum also contain dopamine
sensitive adenyl cyclase which has several of the properties of the
striatal dopamine receptor, (l26, 12, I6l). For example, the
stimulatory/
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stimulatory effect was mimicked by very low concentrations of
apomorphine and prevented by antipsychotic drugs (l49> 127, 47).
A number of neurotransmitters besides dopamine, like serotonin and
norepinephrine, (l25) increase the cAMP content of brain slice. Such
increase apparently results from stimulation of separate and distinct
receptors for dopaminergic, serotoninergic and noradrenergic compounds.
Through the use of specific blocking agents it appears that these
compounds have independent sites of action, (l25).
It has been observed that an enzyme, a protein kinase, that
catalyses the phosphorylation, by ATP, of phosphorylase kinase, is
dependent on cAMP; therefore the level of phosphorylation of substrate
proteins, is mediated indirectly by cAMP. This has led to the idea
that cAMP-mediated phosphorylation of proteins may be involved in
neurotransmission. It has been proposed that this protein
phosphorylation may be involved in changes in synaptic permeability,
transmitter synthesis and phosphorylation of myelin basic protein, (21l).
Adenyl cyclase can be stimulated by low concentrations of calcium,
suggesting that it may have a role in its regulation. It could be
possible that depolarization resulting in an influx of calcium could
affect cAMP mediated processes such as protein phosphorylation.
B2.3 A MODEL TO EXPLAIN TYROSINE HYDROXYLASE REGULATION. AN
ALTERNATIVE EXPLANATION, TO THE FEEDBACK HYPOTHESIS (l).
Roth, in 1975, (256) proposed a model for tyrosine hydroxylase
activation. An increase in impulse flow leads to an increase
in calcium influx. By "some" calcium dependent
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dependent reaction, the adenyl cyclase in the presynaptic membrane is
activated increasing the levels of cAMP, which in turn activates a
protein kinase which could phosphorylate TOH converting it into a
kinetically activated form, or phosphorylate a protein which then
serves as an activator of TOH.
It has been postulated that when the impulse flow is decreased,
calcium influx is diminished triggering a reversable change in the
conformation of TOH causing the enzyme to have an increased affinity
for tyrosine and pterin cofactor and a decreased affinity for end
product inhibition.
To support this model, in soluble preparations of TOH obtained
from rat striatum, it was found that a decrease in the concentration
of calcium resulted in an enzyme which has similar properties to the
enzyme after inhibition of impulse flow (256). This is in agreement
with the increase in dopamine synthesis observed in the striatal
slices when calcium was removed from the medium, (ljl).
An indirect way of testing this model was based on the idea that a
receptor blocker will remove any modulatory influence on TOH by the
receptor, leading to an enhanced activation of T0H. The hypothesis was
tested stimulating the nigro-striatal pathway in intact brains at a
frequency, and for a period of time, such that no further activation
of TOH could be obtained by a possible feedback loop. The
stimulation alone produced a TOH whose kinetics showed an increased
affinity for end product inhibition. The stimulation plus haloperidol
causes an increase in the stimulation induced activation of TOH; that
is, it generates a form of a TOH with a decreased affinity for end




In this model, the more elaborated part is the effect proposed after
an increase in impulse flow leading to an increase in the influx of
calcium which by an unknown process increase the kinetics of TOH.
Not explained in such detail are first, the effect of a decrease in
impulse flow which by the lack of calcium influx also alters the
kinetics of TOH but with an affinity for end product. And second, in
an imprecise way, dopamine agonists and endogenous synaptic dopamine
are believed to exert a braking effect in the synthesis of dopamine
acting on presynaptic receptors. Heceptor blockers, i-n contrast
are assumed to remove that braking effect increasing dopamine synthesis.
This model is supported by the experiments in striatal slices
(section Bl). However the direct and convincing demonstration of this
model has not been done, and until then it can only he considered as a
model. Especially since Lovenberg et al (l92) have been unable to find
the decrease in the affinity of TOH for dopamine, after a reduction in
the concentration of calcium.
B3 PRE- AND/OR POST-SYNAPTIC RECEPTORS.
Antipsychotic drugs concentrate in cell membranes since they are
highly surface active and fat soluble, (150).. This made it difficult
to estimate specific binding sites, until an antipsychotic drug,
butaclamol, which has an active and an inactive enantiomer, was used.
In this way the binding is calculated as the difference between the
amount of radioactive haloperidol bound in the presence of the inactive
and the active butaclamol, (l87).
With/
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With these studies, surprising results have been obtained. The
simplistic idea of a single receptor onto which dopamine (agonists and
antagonists) bind exclusively has been questioned. It seems that two
antipsychotics, haloperidol and spiperone bind to different sites (l87),
perhaps involved not only with dopamine but with serotonin. Spiperone
binding sites seem to be relatively more influenced by catecholamines,
(l87, 181). In the frontal cortex, specific binding of labelled
spiperone or labelled LSD (lysergic acid diethylamide - a possible
serotonin receptor blocker) was inhibited more by serotonin like
compounds than by dopaminergic agonists, (l87). However serotonin is
less potent than dopamine in inhibiting labelled dopamine binding in
4
striatum, (45, 187).
If the concentration necessary to compete for 50^ (lC-50) of the
labelled dopamine binding sites is compared with the concentration
necessary to produce IC-50 of the adenyl cyclase activity, it is
observed that the affinities of catecholamines for labelled dopamine
binding sites in the rat are greater than their potencies in enhancing
dopamine sensitive adenylate cyclase, and by contrast, antipsychotic
drugs, are more potent as inhibitors of adenylate cyclase than of
dopamine binding sites in the rat, (45, 92). The IC-50 for the anti¬
psychotic drugs to compete for labelled haliperidol binding sites is
different from the one for labelled dopamine, (265).
These discrepancies point out that perhaps agonists and antagonists
are not binding to the same number of receptors, or that not only
adenylate cyclase is the dopamine receptor.
Lesions of dopamine cells with 6-hydroxy-dopamine, (6-OHDA, which
produces degeneration of dopamine and noradrenaline containing neurons,
284), are supposed to cause degeneration of the nigro-striatal pathway
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and its terminals. This produced no difference in the labelled dopamine
binding sites in the striatum compared with the unlesioned side (45).
and the adenyl cyclase activity was still observed on both sides (206).
An increase in the receptor affinity in the lesioned side could explain
the lack of difference between the control and lesioned sides. But
also this cqn be taken against adenyl cyclase as the dopamine receptor.
A compound with similar excitatory properties to the amino acid
sodium glutamate, called kainic acid, (22§, when injected into a brain
nucleus, produces degeneration of the cells whereas axons passing
through or terminating in the region appear to he unaffected, (262).
Its neurotoxic effects seem to be similar to the action of sodium
glutamate, which may be due to its depolarizing action, (229).
Injections of kainic acid into the striatum, produced a
significant decrease in adenylate cyclase after 48 hours, whereas the
binding of labelled haloperidol was only reduced by 20/o. If a lesion
of the cerebral cortex followed, the binding of labelled haloperidol
decreased another 50% indicating that most of the striatal haloperidol
receptor sites are probably localized to axons of cerebral cortical
afferents, whereas dopamine sensitive adenylate cyclase is confined to
neurons intrinsic to the striatum, (265)=
All this evidence points out that the problem of the dopamine
receptor is not as simple as it was thought and that it still remains
to be established if the adenyl cyclase is part of the dopamine receptor
and if it is the only one. It also suggests that there are presynaptic
receptors in the terminals of cortical neurons as well as the dopamine
terminals in the striatum.
Carlsson/
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Carlsson (52, 5l), has proposed that pre- and postsynaptic
receptors may he distinguished by the dose relationships for different
actions of apomorphine. Low doses of apomorphine, produce an
inhibition of Dopa synthesis which will not have any observable effect
on a behaving animal, while a dose ten times higher will produce several
alterations in its motor behaviour. Therefore he proposes that there
is a preferential activation of presynaptic receptors which are the
ones that respond to low doses of the drug, and only when it is
are
increased, postsynaptic receptors/activated with their consequences
on motor behaviour.
2C. DOPAMINE-ACETYCHOLINE-GABA INTERACTIONS IN A FEEDBACK LOOP.
Using imoiunohistochemical techniques with fluorescin labelled
antibodies against choline acetyltransferase, (ChAT) it has been
possible the localise some ChAT containing neurons, (141, 201).
Labelled cells and dendrites were observed in the striatum, (l4l) and
after 6-OHDA lesions, in substantia nigra, degenerating dopamine boutons
were observed on dendrites or spines of labelled cells for ChAT, (l4l)
indicating that dopamine cells synapse on ChAT containing cells.
Moreover a 'pile-up' of the enzyme is not observed in the striatum after
lesions of the fibres leaving the nucleus, an effect found in ChAT
containing cells when their axons are cut, (l4l). This indicates that
these cells are contained within the nucleus as interneurons.
It has been shown that Acetylcholine release and turnover is
increased in the striatum by antipsychotic drugs, and decreased by
apomorphine or L-Dopa, (137, 194, 18). In other brain areas it
does not change, (l8, 60, 137), indicating that probably it is in the
striatum/
27.
striatum where dopamine terminals inhervate a relevant number of
cholinergic neurons.
After a blockade of Ach synthesis with hemichdLinium-3, the rate
of disappearance of Ach is increased by antipsychotic drugs, (137).
It appears then, that the decrease in Ach levels after antipsychotic
drugs could be due to an increased rate of utilization of striatal Ach.
It thus seems that antipsychotic drugs enhance and dopamine agonists
decrease the activity of striatal cholinergic neurons.
Following the administration of neuroleptic agents, the enhanced
Ach liberation could reflect disinhibition of cholinergic neurons due
to removal of an inhibitory dopaminergic input.
Electrical stimulation in substantia nigra, reduced the liberation
of Ach in striatum, (l8), supporting the idea of dopamine as an
inhibitory input into Ach cells there. This input seems to be tonic,
since transection of the dopamine pathway results in increased
spontaneous Ach release in the striatum, (137).
2C.1. ALTERNATIVE EXPLANATION TO THE FEEDBACK HYPOTHESIS, (ll).
At this stage the results could be summarized by saying that there
appears to be an inhibitory synapse of dopamine containing terminals
onto Ach containing cells in the striatum, however, although this could
be the case, other results complicate this oversimplification.
Cholinomimetic agents (like, Oxotremorine, physostigmine or
carbachol) increase dopamine release, measured by means of a push-pull
cannula, (19) or as an increase in labelled dopamine formed from labelled
tyrosine, (l20). In the same way, cholinergic blockers (muscarinic
and nicotinic) decrease the release of dopamine, (l9, 12Q). Based on
this/
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this evidence it has been proposed that the Ach containing neurons on
which dopamine terminals synapse, send in turn a collateral which
synapses into the dopamine terminal, facilitating dopamine release,
(19, 120, 20). In accordance with this it was found that atropine
blocks the haloperidol induced increase in dopamine (l9). (Fig.1).
Fig. 1 HYPOTHETICAL REPRESENTATION OF A DA-Ach INTERACTION IN THE
STRIATUM.
(-) inhibitory, (+) facilitutory influence, ST. = Striatum,
SN = Substantia Nigra.
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The effects of manipulating GABA on dopamine release are
contradictory. While it has been shown that intraperitoneal injection
of picrotoxin (GABA, receptor blocker) increases dopamine release, (282),
i
it has also been found that it decreases the release of newly synthesized
labelled dopamine from labelled tyrosine (l2l). GABA and Muscimol
(a GABA agonist) enhanced the spontaneous release of dopamine. It has
been proposed that Ach collaterals synapsing on dopaminergic terminals
have GABA receptors that when activated in the presence of GABA increase
the release of Ach, (l2l), (Fig.2).
Fig. 2 HYPOTHETICAL REPRESENTATION OF DA-Ach- GABA INTERACTION IN
THE STRIATUM.
Symbols as in Fig. 1.
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The models of presynaptic control of dopamine release are not
explained in such detail as to include the mechanisms involved for
such control, however there is the implicit idea of a depolarization
or a hyperpdarization effect.
If acetylcholine is considered to facilitate the dopamine containing
terminals with influx of calcium, the TOH kinetics will be altered in
such a way that the increase in dopamine release after haloperidol will
not be observed, (Section, 2.B, 2, 3)- Of course, since both are
models they need not necessarily both agree.
If depolarization is still considered as a possible mechanism,
the first thing that can be concluded is that Ach is producing
presynaptic inhibition, and therefore decreasing the amounts of
transmitter available. Which does not fit with the idea of Ach
producing an increase in dopamine release after haloperidol.
Hyperpolarization of the presynaptic terminal perhaps could explain
the results, since it has been shown that even though it is more
difficult to reverse the membrane potential, when it is reversed during
an action potential, it releases more transmitter, (91)„
Examined carefully, the models of dopamine control by Ach and GABA
interactions somehow do not seem to be very clear. Evidence for Ach-
GABA interactions is also needed.
2.D DENDRITIC CONTROL OF DOPAMINE RELEASE.
By the evidence presented so far, while it cannot be excluded
completely/
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completely that the receptors involved, in the regulation of dopamine
release are located at the postsynaptic cell bodies, there are also
observations indicating that there is a local receptor-mediated
feedback mechanism, confined to the dopaminergic nerve terminal area-
It has been found (Section 3, E.3) that nigral dopaminergic cell
bodies respond to locally applied dopamine and apomorphine, with a
decreasedfiring and that this effect can be blocked by haloperidol,
(39, 4l)• Since nigral dopaminergic cells do not seem to receive any
input of dopaminergic nerve terminals, it was suggested that the
dopaminergic receptors possibly located at the cell bodies and at nerve
terminals "serve as sensors for the neuron's own transmitter in the
medium surrounding it", (53). The term autoreceptor has been proposed
(52), which includes the so called presynaptic receptor at terminals in
the striatum, as well as the receptors located in the cells bodies and
dendrites in substantia nigra.
On the other hand, varicose dendrites extending to the substantia
nigra reticulata were observed by fluorescence microscopy, (3l).
Furthermore, the fluorescence disappeared after injecting reserpine
12-33 hours before killing the animal and was increased after incubation
of the slides with dopamine, (3l)• This indicated that probably the
dendrites and cell bodies take up, store and release dopamine, as do the
axon terminals. To strengthen this point, it was found that in slices
from rats' substantia nigra, labelled dopamine was taken up probably by
dopamine dendrites and cell bodies, (ll9), and possibly by axon
collaterals too. To minimize the possible contribution by cell bodies,
the substantia nigra compacta was separatedfroin the substantia nigra
reticulata. After incubation in dopamine, both areas showed an increase
in/
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in their dopamine content, (73). Suggesting therefore a dopamine take
up by dendrites as well as cell bodies.
Taking advantage of the ability of nigral tissue to incorporate
labelled dopamine, it was shown that once it is taken up,it is also
spontaneously released, (73). After exposure to potassium, (which
stimulates calcium dependent transmitter release J32), an efflux of
labelled dopamine was observed, providing the superfusion medium
contained calcium (73,119)- This shows that dendrites in the
substantia nigra reticulata as well as dopamine cell bodies in
substantia nigra compacta, incorporate and release dopamine.
With this evidence it was thought that if dendrites are
liberating their transmitter, and if the concept of autoreceptors is
true, an obvious place for those dendrites to act is on the cell bodies
or dendrites of neighbour dopamine cells (lateral inhibition) or on the
same cell (auto-inhibition).
The idea of lateral inhibition was strengthened when evidence for
dendro-dendritic associations containing vesicles (l39), was taken into
account. However, in another similar study, (73) no morphological
signs of synaptic conctacts, (such dense projections, membrane
attachments, vesicles or membrane thickenings) were found between
dendrites. On the other hand even though dendro-dendritic appositions
were frequently observed, dendrites were also found to associate with
blood vessels, (31, 73). But again no evidence was found of synaptic
contacts, (73). Dopamine released from dendrites could act on blood
vessels and influence microcirculation in the substantia nigra, but so
far there is no evidence to support such hypothesis.
The lack of consistent evidence about dendro-dendritic synapses,
weakens/
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weakens the point that dendrites may act on neighbouring dendrites.
And this is emphasized when studies on adenyl cyclase are reviewed.
If the adenyl cyclase is considered to be associated with the
dopamine receptor (Section 2, B.3) and if the concept of autoreceptor
is true, there must be a dopamine-sensitive adenyl cyclase in substantia
nigra. This appeared to be the case when in homogenates of the
substantia nigra reticulata, a dopamine-sensitive adenyl cyclase was
found, (l63). However, after 6-OHDA injections in substantia nigra,
(which produces degeneration of dopamine and noradrenaline containing
neurons, >284), no difference was found in the dopamine stimulated
adenyl cyclase from intact and injected sides, (l63, 236, 117).
Therefore the dopamine receptor did not appear to be in the cell bodies
or dendrites of dopamine neurons.
In order to find out where the adenyl cyclase was located,
different experiments were done. Hemisections between the substantia
nigra and striatum, (267, 117), lesions in the globus pallidum, (236)
or in the striato-nigral pathway, (267), indicated that the adenyl
cyclase was present in the afferent fibres interrupted by the lesion,
since the dopamine-sensitive adenyl cyclase was markedly decreased
after the lesions.
Only the afferents coming from the striatum and globus pallidum
seemed to be involved, since a hemisection posterior to substantia nigra,
interrupting the afferent serotoninergic fibtes from the raphe nuclei,
did not alter the adenyl cyclase in substantia nigra, (ll7).
With this evidence, it has been suggested that dopamine released
from dendrites may act on the afferent fibres innervating substantia
nigra and controlling the release of their transmitter among nigral
cell/
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cell bodies or dendrites, ('73, 236, 117, 267).
r
D°1 AN ALTERNATIVE EXPLANATION TO THE FEEDBACK HYPOTHESIS, (ill)
D.l.l GABA CONTAINING AFFERENTS.
Since gaba afferents from the striatum have been described
(Section A„2) an alternative model for the mechanism of action of the
antipsychotic drugs is proposed, by saying that dopamine interacts with
the adenyl cyclase receptor in gaba afferents, in such a way that when
dopamine is present, gaba is released inhibiting the neurons, and when
a dopamine blocker is given, then gaba is not released and the dopamine
neurons are disinhibited, (ll7, 267), (Fig.3A).
Fig.j. hypothetical representation OF gaba-dopamine (a) and (b)
substance p-dopamine interactions in substantia nigra.
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D.1.2. SU3STMCE F CONTAINING AFEEREETS.
Substance Pisan wndecapeptide, highly concentrated in the dorsal
horn of one spinal cord of cats and rats, and an excitant of motoneurons,
(94). It has been found in different parts of the brain, (l59) and a
stimulus evoked release of Substance P has been demonstrated from rat
hypothalamic slices, (l52) making it a candidate for a neurotransmitter
in the central nervous system, (74).
The substantia nigra has one of the highest concentrations of
substanceP, and hemisections or lesions interrupting the pathway from
striatum and globus pallidus to substantia nigra produce a decrease
in the amount of substance P in substantia nigra which is correlated with
the decrease in GAD activity that these lesions also produce, (ll7, 236
and Chapter II, Sections D.l and E.4). Electrothermic lesions in the
striatum and globus pallidum, also produce a significant decrease of
both GAD and substance P, (l60). Immunohistochemical techniques showed
that some cells in the globus pallidus and striatum were substance P
positive, (l60)« Therefore, since pathways containing substance P are
also interrupted in the studies showing adenyl cyclase in the afferents
to substantia nigra, a modulatory action of dopamine on these fibres is
also mentioned, (236, 117), (Eig. 3B).
This model is not very specific, and can be subjected to similar
criticisms to the model of Ach, GABA and dopamine interactions, (Section
2.C); it leaves the modulatory action of dopamine, in this case, to an
unknown mechanism which facilitates or inhibits GABA or substance P.
It/
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It is based on the activity of adenyl cyclase which may not be the only
dopamine receptor if it is in fact the receptor, (Section B.3).
Even though this evidence contributes to the idea that there is
also a release and turnover of dopamine in substantia nigra, the model
could not be used alone to explain the changes in dopamine turnover in
the striatum, since it could not explain the effects of nerve impulse
blockade (Section B.2) or in vitro studies of striatal slices, (Section
B.l).
2oE PREVAILING INTERPRETATIONS.
It is not possible to exclude completely with the evidence presented
so far, that fibres to substantia nigra do not exert any effect on
dopamine cells, but it is also clear, that the striatum and the substan¬
tia nigra, could regulate their synthesis of dopamine if left without
any communication from each other.
Several hypothesis have been tested in order to find how is'/that
these structures regulate the synthesis of dopamine, and so far none of
them seem to be completely satisfactory.
A carefully elaborated model is the one presented by Roth, (Section
2.B.2), however its main criticism could be that other researchers have
not been able to corroborate his results. Furthermore it is based on
the activity of an adenyl cyclase as the presynaptic dopamine receptor
whose existence is not at all clear, (Section 2.B.2).
A much more imprecise model is the one involving interneurons,
dendrites and axon collaterals of Ach, and GABA containing cells,
(Section 2.2.C). No doubt that these interrelations may exist but in
this case more information is needed about these interconnections and
their/
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their effects, before any conclusions can be drawn. It is however a
good approach to the problem, since it conceives the system in a more
realistic way.
The evidence showing dopamine release in the substantia nigra, and
its possible control over the afferents in the substantia nigra,
(Section 2D) again shows how complicated this interaction can be.
It also points out that there might be, at least, two mechanisms for
the control of dopamine turnover, one located in the substantia nigra,
and the other in the striatum, so that if the system is disconnected it
still can work independently.
3. ELECTROPHYSIOLOGICAL EVIDENCE: RECIPROCAL RELATIONS BETWEEN THE
STRIATUM AND THE SUBSTANTIA NIGRA.
According to the feedback hypothesis, dopamine exerts an inhibitory
action on striatal cells, and these in turn, decrease dopamine neurons
activity in the substantia nigra; process which is reversed after
antipsychotic drugs, (Section 2.A). This hypothesis inspired many
electrophysiological experiments, some of which, together with others
not directly related to this hypothesis, will be examined in this
section,,
3.A METHODOLOGICAL CONST PERATIOITS.
Before studying in detail the results of these electrophysiological
interelations, some problems which make the interpretation of the
results difficult, must be mentioned.
l) Those experiments using electrical stimulation of the striatum or
substantia nigra, cannot completely guarantee that the stimulation is
localized/
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localized, not only by the kind of electrode or amount of current used,
(242), but also by the spread of current to other areas. Attempts to
rule out stimulus spread, have included lesions of areas around the
stimulating site (113, 148, 113), arrays of stimulating electrodes, so
that the effects of activating adjacent tissues could be compared with
those elicited by nigral stimulation, (l48, 65); and manipulating
electrode depth, (l48). In spite of all these techniques, one should
bear in mind that the stimulation may excite other neurons of which
only a portion actually projects to the recorded site, and that
polysynaptic circuits may be involved for long latency responses; or
antidromic activation of other fibre systems may be confused with the
effects of orthodromic stimulation, (249, 306).
2) A problem frequently found in electrophysiological studies, of the
striatum, is the paucity of spontaneously discharging cells; in some
cases, L-glutamic acid or dl-homoeysteic acid (amino acids which excite
cells in the nervous system, 270) is iontophoresed in order to
increase the firing rate of these cells, (l45, 64); in those cases
the actions of other experimental manipulations must be interpreted
against that artificial background of the response.
3) Some of those "silent" neurons are also excited by stimulation of
the thalamus, cortex, (113, 145), or from within the caudate, near the
recording electrode, (l95); such procedures, are useful for studying a
selected group of neurons, however, these cells may not be
representative of all the neurons innervated by substantia nigra
afferents, in this particular case.
4)/
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4) Intracellular recordings have the advantage of recording membrane
potential changes, even when action potentials are absent, although they
introduce a probable sampling bias in favour of larger cells.
5) Studies from the substantia nigra often fail to show a detailed
anatomy of the recording or stimulating sites, therefore the electrode
could be in the pars compacta or pars reticulata, which could make the
interpretation of the results different if the anatomical connections
are taken into account, (Section 1C.)
6) In some animals the cortex overlying the caudate nucleus is
removed, (l71, 113, 170). In these cases although the placement of the
recording electrode may be facilitated, and the micropipetes block less,
the activity of the cells may not be the same in view that cortical
projections to this area are destroyed, and spreading depression is
also produced, (llO, 166).
7) In general it is important to point out that it is necessary to:
A) make a systematic identification of cells .in terms of the input they
receive from different structures, as well as its nature, (mono or
polysynaptic) and B) do combined pharmacological and electrophysiological
experiments.
3B. NEURONAL ACTIVITY IN THE STRIATUM AFTER STIMULATION OF THE
SUBSTANTIA NIGRA.
Even before the pathway from the substantia nigra to the striatum
was anatomically established, electrophysiologists were trying to
determine whether or not they could find responses in the striatum
after/
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after substantia nigra stimulation, (ll3, 145).
Most of these experiments, were done in cats, some immobilized
with gallamine triethiodide, (l48, lOl), or with a section through the
midbrain (cerveaux isole preparation), (203, 304, 113, 64, 302), after
which only local anaesthesia is required.
When the activity of cells in the caudate nucleus or putamen was
increased by iontophoresis of amino acids (Section 3A), the stimulation
of the substantia nigra, produced an inhibition of the firing rate
which lasted approximately 40-60 msec, (304, 203, 64). A similar
experiment done in immobilized rabbits reported a longer inhibition,
80-350 msec, (l45). An increased discharge has also been observed
after the inhibition, (l45, 64, 113).
A focal negative potential concomitant to the stimulation is
sometimes described; this potential has a peak latency of 2.5-6 msec,
and its amplitude is variable and dependent on stimulus parameters,
(lOl, 113, 302, 304). It probably indicates a current flow from a
population of cells near the recording electrode, possibly innervated
by the stimulated fibres.
Sometimes, an action potential is associated with this focal
potential, (302, 101, 304, 113) its latency varies from one experimental
report to the other ranging from about 5 msec, (302, 304) to 16-20 msec,
(lOl, 113). This spike fails to follow high frequencies (50-100 p/sec)
suggesting it is orthodromic, confirmed by the fact that it does not
collide with spontaneous spikes, (105); spikes of latencies less than
4 msec, have been considered as antidromic potentials evoked in
striato-nigral fibres excited by nigral stimulation, (ll3) • The
conduction velocity calculated for this action potential, accounting
for/
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for one synapse, falls between the range of conduction of non-mylinated
fibres, (0.5-2.0 m/sec), (l05, 113, 170) which agrees with the anatomy
of this pathway, (Section l). The orthodromic spike produced by
nigral stimulation, contrasts with the inhibition observed after an
induced excitation by iontophosis of amino acids, and even in these
conditions, in some cases, a further excitation has been observed after
the stimulation, (64). It has been reported that this spike is blocked
by intravenous injection of haloperidol in anaesthetized rats, (240) or
by superfusion of haloperidol through a cup placed on the surface of
the caudate nucleus of cats, (l04), indicating that this potential is
mediated by dopaminergic receptors.
Some spontaneously active cells have been excited, inhibited, or
unaffected by nigral stimulation, (lOl), suggesting that not all
striatal cells are innervated by dopamine containing nigral afferents
and that even those which seem to receive an input from substantia
nigra, show different responses. In order to explain this discrepancy,
two dopamine receptors have been proposed, one mediating inhibition
and the other excitation, (302, 203); it has also been proposed that
there are two kind of cells, some inhibited by nigral fibres, and
sensitive to iontophorized amino acids, and some excited by nigral
stimulation which are not spontaneously active and have a high safety
factor following high frequencies of stimulation, (up to 300 p/sec, 105).
Intracellular records of caudate cells also show different
excitatory or inhibitory post-synaptic potentials (EPSP's and IPSP's)
to nigral stimulation.. These span the whole range from IPSP's alone,
through EPSP-IPSP combinations, to EPSP's alone (l48, 113, 171, 38).
The EPSP-IPSP arrangement seems to predominate, (ll3, 38, 17l); the
IPSP's/
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IPSP's recorded show a longer hyperpdarization period when compared to
similar responses produced by cortical or thalamic stimulation, (l48)
and frequencies of stimulation higher than 10 p/sec led to hyperpolar-
izations even when responses to single stimuli produced EPSP's, (148).
This agrees with the observation that a longer lasting inhibition of
induced discharge is observed after repetitive stimulation, (64).
The EPSP-IPSP sequences have been explained as an initial
excitation produced by the stimulated input, followed by inhibition
generated from within nucleus, mediated by the interneuron collaterals,
(148, 38).
The relationship between the stimulated fibres and the recorded
cells has been considered as monosynaptic, because the EPSP's keep a
constant rising point regardless of the stimulus intensity or frequency,
(171, 113). This monosynaptic input appears to be on interneurons
since antidromic stimulation of cells whose axons leave the striatum
(striato-nigral pathway) shows that these do not have monosynaptic
potentials, (l70). Apparently these interneurons do not only receive
inputs from the substantia nigra but from the motor cortex and the
centromedian and parafascicular nucleus of the thalamus, (l71, 38).
Inputs which seem to converge onto a single neuron as there was a
summation of their corresponding EPSP's after combined stimulation of
these areas, (l7l).
Without taking into account the possibility that these results are
due to antidromic stimulation of striato-nigral fibres, (249, 306),
the most consistent results could perhaps be summarized as follows:
it appears that the substantia nigra stimulation most frequently
induces an excitation followed by an inhibition probably on caudate
interneurons,/
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interneurons, represented by EPSP's-IPSP's sequences. Although in
■spontaneously or induced active cells, it produces an inhibition,
suggesting at least two kinds of neuronal populations from
electrophysiological criteria.
3C. ELECTROPHYSIOLOGICAL RESPONSES OP CAUDATE NEURONS TO DRUGS.
CI. DIRECT APPLICATION OP DOPAMINE.
Dopamine ionotophoretically ejected in the caudate nucleus of
anaesthetized or decerebrated cats and monkeys produces a similar
mixture of responses. It decreases the firing rate of spontaneously or
induced active cells, (l02, 65, 261, 268, 33, 203, 303). A small but
consistent group of cells is facilitated, (203, 303) many neurons do not
respond, and a few (14-18fo) show a combined effect, with an initial
inhibition followed by an excitation, (303, 302).
The effects of iontophoretic dopamine on caudate neurons responding
to nigral stimulation have been reported only in a few instances (303,
102, 65, 261), in these cases both dopamine and nigral stimulation
reduced the firing rate of cells (l02, 65). Also iontophoretically
applied dopamine potentiated the inhibition produced by electrical
stimulation (26l). Units which responded to stimulation by evoked
spikes or increased firing rates, have been reported to be depressed,
(203), unresponsive, (102) or show mixed responses (65) to dopamine.
Some of the confusion in this point, may be due to different experi¬
mental designs (e.g. anaesthesia, vrs decerebration, etc) and different
recording sites.
If the depressant effect of nigral stimulation and iontophorized
dopamine,/
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dopamine, share a common mode of action, it should be possible to block
them both, by a blocking agent., however, adrenergic alpha-receptor
blockers, (phenoxybenzamine and phentolamine) antagonized the action of
dopamine, but not the effects of nigral stimulation (203, 304, 65).
Chlor promazine, iontophorized to the caudate nucleus of anaesthetized
monkeys (303) abolishes the effects (facilitation and inhibition) of
iontophorized dopamine. The same has been observed in recordings from
the putamen of anaethetized or decerebrated cats, (302, 304), but no
stimulation of the substantia nigra was done in these cases. Therefore
it remains to be established if both, nigral stimulation and
iontophorized dopamine have a common mode of action.
C2. EFFECTS OF ACETYLCHOLINE (Ach) MP GAMMA-AMINO-BUTYRIC-ACID (GABA).
As has already been mentioned, (Section 2.A.2; 2.C), there are
GABA and Ach containing neurons in the striatum, possibly involved in
a feedback control of dopamine synthesis. Electrophysiological studies
have tried to clarify the effect of these transmitters on cell activity
in the caudate nucleus, however the results do not seem to contribute to
this aim.
Iontophorized Ach, mainly increases the firing rate of spontaneously
active cells in the caudate nucleus, (29, 28, 268, 33), although less
than 1C$ of the cells showed an inhibition or did not respond, (268, 33).
Anaesthetics (chloralose, or pentobarbital) decreased the facilitatory
effect of Ach, (33). A lesion of the nigro-striatal pathway enhanced
the effect of Ach, (268) suggesting that after dopamine denervation,
this population of recorded cells became more sensitive to Ach.
Intracellular recordings of striatal cells in immobilized rats, (24),
show/
45.
show that iontophorized Ach produces EPSP's with a subsequent increase
in the firing rate. GABA iontophorized into the striatum of rats,
abolished spontaneous activity recorded intracellularly and induced
IPSP's (23, 25); picrotoxin reversed its effect, (23).
These results give some evidence about the intrinsic role for
Ach and GABA in the striatum proposed with the biochemical results,
(Section 2.C) but much more experiments are needed to confirm the
relations proposed by the biochemical models.
C3. PREVAILING INTERPRETATIONS.
To make a summary of these electrophysiological results without
eliminating potential relevant information is almost impossible,
therefore, this is only to point out the most consistent results from
different experimental reports.
It appears that in agreement to what is proposed in the feedback
hypothesis stimulation of the substantia nigra leads to inhibition of
spontaneous or induced activity of caudate cells, (304, 203) and that
this effect is reproduced by the direct application of dopamine, (l02,
261, 203).
In some cases stimulation of the substantia nigra leads to
facilitatory effects on caudate cells, producing spikes or increasing
their firing rate, (302, 105, 113). Confusing results are obtained when
dopamine is iontophorized, sometimes these cells are inhibited,
facilitated or do not respond, (203, 102, 65). In order to explain the
contradictory facilitation which does not agree with the supposed effect
of dopamine, two different kinds of neuronal populations have been




spike produced after nigral stimulation seems to be mediated by
dopaminergic receptors, since it is abolished by haloperidol, (l04,
249)„ This action potential has allowed the calculation of the
conduction velocity, suggesting that the excitatory nigro-striatal
pathway is slowly conducting, (0.5-2.0 m/sec).
In view of the possible presynaptic regulation of dopaminergic
terminals, (Section 2.C), as well as the apparent complicated
connections inside the nucleus, it seems naive to look at the effect
of drugs on several cells as if they belong to the same population.
Probably most of the conflicting results are due to this approach.
3D. NEURONAL ACTIVITY IN THE SUBSTANTIA NIGRA APTER STIMULATION OF
THE CAUDATE NUCLEUS.
Extracellular recordings of substantia nigra cells after caudate
stimulation with a single pulse, produces in most cases, (60-90$) an
inhibition of the firing rate of spontaneously or induced active cells,
(305, 88, 204, 103, 107, 134, 108). These results are common to all
the experimental animals, (e.g. rat, cat, monkey) or their experimental
condition, (e.g. anaesthetized or cerveaux isole) . In a smaller but
consistent number of cases, (always less than 50$), an increase in the
firing rate preceded or followed the inhibition, (88, 103, 107, 108, 113).
A positive field potential is usually recorded in cats and rats,
which correlates with the onset and duration of the inhibition of the
firing rate, (88, 305, 204, 24l), probably related with focal current
movements.
There is a disagreement between the experimental reports about the
duration of the inhibition, but this would be expected as inherent
changes/
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changes in the experimental conditions; for instance, it has been
demonstrated that in rats, the latency of the inhibition shifts from
5«4 to 8.9 msec from urethane to pentobarbitone anaesthesia, (88).
Intracellular recordings in cats, agree with the results
obtained extracellularly; in most cells (more than 50%), IPSP's are
observed following stimulation of the caudate nucleus, (305, 114).
In a few cases, (less than 15%) EPSP's are recorded alone, (ll4) or
preceding the IPSP's (305). It has also been reported that sequences
of EPSP-IPSP's as a result of repetitive stimulation, (8 p/sec) in the
caudate nucleus of cats, are obtained in the substantia nigra as the
rule and not the exception, accompanied by action potentials, (ll3).
Due to the constant shape and latency of the PSP's and the lack of
temporal facilitation, these are considered as monosynaptic potentials,
(305, 114, 113).
Some of these PSP's are reported to have latencies between
3-5 msec and some between 10-15 msec, (305, 113, 114). It has been
proposed that fibres of different diameter and conduction velocities
convey the impulses from the caudate to the substantia nigra; conduction
velocities of about 5 nj/sec have been calculated for the short latency
responses (ll4, 113); and between 0.9-1.0 ni/sec for the long latency
ones, (ll3, 305). There seems to be no relation between the latency
and the nature of the PSP's (excitatory vrs inhibitory).
Extracellular recordings in conscious monkeys, report similar
short and long latency inhibitions (l07). Conduction velocities
falling in the same range, have been reported from rats, (88), although
the monosynaptic nature of the response was not corroborated.
The/
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The cause of the excitatory and inhibitory responses of nigral cells
has been attributed in most cases, as possible involvement of different
synaptic transmitters, (88, 114, 108). However, the possible stimulus
spread to cortico-fugal fibres has been discussed, (l34), although the
lack of movement in anaesthetized stimulated animals questions this
possibility, (l08).
Pew experiments consider the difference between the pars compacta
and the pars reticulata of the substantia nigra, (Section l). One
report, describes that from the substantia nigra pars compacta only 60%
of the cells were inhibited by striatal stimulation, while 35%> were
inhibited in the pars reticulata in rats, (88).
Correlating the anatomical placement of the electrode with the
activity of the cells, it has been observed in rats, that cells in the
substantia nigra pars compacta, have firing rates of 3-10 spikes/sec
(88, 300) and peak inter-spike-intervals, (iSI's) between 60-250 msec
(300). On the contrary cells in the pars reticulata have firing rates
of 15-20 spikes/sec and ISI's between 10-50 msec, (88, 300). This has
been considered as "the signature of the cells" (300), and could be used
as a preliminary guide for their identification.
Summarizing, it could be said that in agreement to the feedback
hypothesis, mainly inhibitory responses are observed in the substantia
nigra after caudate nucleus stimulation, although consistent excitations
are also detected, (305, 88, 204); possibly due to the participation
of different synaptic transmitters, (88, 114, 108). Fibres of
different conduction velocities are considered to be the cause for short
and long latency responses, believed to be monosynaptic, (ll3» 114, 305).
As seen in the case of caudate cell recordings, there is a need for
careful/
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careful identification of recorded neurons; perhaps the differences
observed in the firing rate and ISI's in both areas of the substantia
nigra, (88, 3Q0) should be used more often to differentiate them.
3E ELECTROPHYSIOLOGICAL RESPONSES OF SUBSTANTIA NIGRA CELLS TO DRUGS.
As has been previously mentioned, afferent fibres from the
striato-nigral pathway may contain GABA, (Section 2. A2) and Substance
P (Section 2.D1.2); on the other hand, dendrites or axon collaterals
of dopamine cells also seem to release dopamine into the substantia
nigra (Section 2.2.D). Therefore, it is relevant from the feedback
point of view to study the effects of these drugs and their agonists
and antagonists on the activity of nigral cells, and relate them to the
electrophysiological results mentioned on the previous section.
El. GABA AND NIGRAL CELL ACTIVITY
As electrophysiological studies indicate there is an inhibitory
input to the substantia nigra from the caudate nucleus in cats and
monkeys, and the striatum of rats. Since GABA is believed to be the
inhibitory transmitter in some synapses in the nervous system of these
animals, (252) and it is found in the substantia nigra, most of it
presumably coming from the striatum, (Section 2.A.2), it is logical to
suggest that GABA may be involved in the inhibitory response observed
after the electrical stimulation of this nucleus.
Recordings of spontaneously active neurons in the substantia nigra
are inhibited by the iontophoresis of GABA in this region in rats, (76,
230, 295) and the effect is reversed by picrotoxin either iontophorized
(76) or injected intravenously in cats, (24l). The effect of GABA .is
also/
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also abolished by iontophoretic application of bicuculline, another
GABA antagonist, (230). The positive field potential which accompanies
the inhibition of the firing rate, is also reduced ai'ter the intravenous
injection of picrotoxin, (24l).
E2. SUBSTANCE P AND NIGRAL CELL ACTIVITY.
The depolarizations and action potentials also observed after
caudate nucleus stimulation could be due to the release of substance P
found in the striato-nigral pathway (Section 2, D.1.2). It has been
shown that when iontophorized, it depolarizes cells in the ventral horn
of the spinal cord (l75) and cortical pyramidal cells (257) of rats,
and in the cuneate nucleus of cats (l80), suggesting that it could
possibly act as an excitatory transmitter in the central nervous system.
Accordingly, after the iontophoretic injection of Substance P in
the cells of the substantia nigra pars compacta of rats, there is an
increase in the firing rate, (295, 8l).
Even though the excitation produced after the application of
substance P seems to be strong, it has been reported to be slow in its
onset, taking from 7 to 30 sec to produce its effect, (l80, 81, 237).
Therefore, there is an argument about whether it is a "normal" synaptic
transmitter capable of mediating transmission quickly (in terms of
milliseconds) or on the contrary, influencing neuronal excitability over
long periods, (l80). Consequently, although it seems to act by
depolarizing cell bodies, the function of substance P in general does
not seem to be clearly understood.
E3. Dopamine and Nigral cell activity./
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E3. DOPAMINE MP NIGRAL CELL ACTIVITY.
E3.1 AMPHETAMINE.
This drug appears to facilitate catecholamine action by promoting
release and blocking reuptake at presynaptic terminals, (292, 27).
In the periphery, amphetamine seems to act by releasing
noradrenaline from its terminals, although it has itself little or no
direct effect on adrenergic receptors, (50) . It seems to act
similarly in the brain by releasing noradrenaline and dopamine from
nerve terminals, (209). This is supported by the finding that
pretreatment with a drug that inhibits catecholamine biosynthesis,
alpha-methyl-para-tyrosine (AMP!) prevents the amphetamine stimulation
of behaviour (e.g. increased locomotor and stereotyped behaviour, 9)•
Furthermore amphetamine produces an increase in the accumulation of
the O-methylated products of dopamine and noradrenaline (normetanephrine
and methoxytyramine) after inhibition of monoamine oxidase, indicating
an increase in the release of catecholamines (9). Perfusion of dextro¬
amphetamine through a push-pull cannula in the caudate nucleus of cats,
results in a significant increase in the concentration of dopamine
released (267, 202). The uptake of radioactive dopamine is'
significantly reduced in the rat striatum after dextro or levoamphetamine
(7l). In rats injected intraperitoneally with amphetamine 90 min
before their sacrifice, the synthesis of dopamine is also reduced as
indicated by the levels of radioactive water and dopamine in striatal
slices incubated with radioactive tyrosine, (27).
Although it seems clear that the effect of amphetamine is presynaptic
releasing catecholamines from their terminals, there is also evidence
suggesting/
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suggesting that it might act postsynaptically directly on catecholamine
receptors, (l06).. Recording of cells in the caudate nucleus of cats
after injection of 6-OHDA decreased their firing rate as in control
animals, after amphetamine administration suggesting a posi^naptic
effect since the catcholamine terminals were destroyed by the injection
of 6-OHDA. However, since the dopamine content in this nucleus was
only reduced by 42-87^, remaining undamaged terminals could be the
responsible for the observed effect.
E3.2 EFFECT OF DOPAMINE AGONISTS. ANTAGONISTS MP RELEASING AGENTS.
The simplistic idea that a neuronal cell body and dendrites only
receive the messages transmitted by other neurons, has become more
complicated after what perhaps started as a control experiment looking
at the effect of these agents in the substantia nigra.
Intravenous injection of apomorphine, decreased the firing rate
of cells in the zona compacta of the substantia nigra and this was
reversed by the systemic administration of haloperidol or chloropro-
mazine in anaesthetized or unanaesthetized paralysed rats (2, 39, 1, 44).
L-Dopa which presumably is converted into dopamine thereby increas¬
ing the amount of dopamine potentially available, also depresses the
firing rate of these cells (39) •
Injections of 6-OHDA into the bundle of fibres leaving the
substantia nigra, which presumably destroys dopamine cell bodies in
this area, leaving other possible dopamine interneurons intact, not
only reduces the fluorescence in this area homogeneously, but produces
a selective loss of single units which had the firing pattern and
responses to drugs characteristic of these cells, (l); confirming
that/
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that the cells in the substantia nigra zona compaeta were the ones
responding to the drugs. These results lead to the conclusion that
the neurons which were producing dopamine as their transmitter also
responded to it, suggesting they had dopamine sensitive receptors in their
cell bodies, (l), which were later termed "autoreceptors", (52),
(Section 2, 2.D) .
Amphetamine injected intraveously also reduced the firing rate in
the zona compacta of the substantia nigra and the effect was prevented
or abolished by the administration of antipsychotic drugs, (39, 40, 41)•
Pretreatment with MPT, abolishes the effect of amphetamine (39, 132),
suggesting that in fact it decreases the firing rate by releasing
dopamine. This evidence was considered to give great support to the
feedback hypothesis; it was concluded that amphetamine was facilitating
the release of dopamine in the terminals from nigral cells in the
striatum and that it was interacting with receptors on postsynaptic
cells which in turn sent their axons to the substantia nigra producing
the observed inhibition, (Pig. 4).
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Pig.4 HYPOTHETICAL REPRESENTATION OP THE FEEDBACK PATHWAY, (l52)
See Sections E3.2 and 5.P. Symbols as Pig. 1.
3F. IS THE ELECTROPHYSIOLOGICAL EVIDENCE CONSISTENT WITH THE
FEEDBACK HYPOTHESIS?
By 1973, all the electrophysiological results seem to fit into this
hypothesis (39> 52). The electrophysiology of the striatum was not
taken much into account, but because of its contradictory results, it
did not produce any conclusive evidence against this idea.
Further support was given once more by Bunney and Aghajanian in
the same years, (40). They transected the brain in front of the
substantia/
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substantia nigra with a retractable knife, immediately before the
recording. This reduced the effect of the intravenous injection of
amphetamine causing "only a slight decrease in the activity below
baseline rate", even at doses 8 times higher than usual, (40).
Moreover, iontophoretic injection of amphetamine into the zona
compacta of the substantia nigra of normal rats, caused "a minimal
slowing" of the firing rate of these cells, (40). It was concluded
that the striato-nigral pathway was needed for the effect of amphetamine
to take place, (Fig. 4).
Two years later, in 1975, what had seemed a coherent explanation
was questioned by another group of researchers, (Groves et al, 129)-
Local injection of amphetamine through a cannula, placed in the striatum
of rats, was reported to speed up cells in the substantia nigra pars
compacta and reticulata, while the opposite effects rare observed with
the infusion of amphetamine in the zona compacta of the substantia
nigra; cells in this area slowed down and simultaneous recordings
indicated that cells in the striatum increased their firing rate.
Since by this time it had been shown that dendrites, cell bodies, and/
or axon collaterals in the substantia nigra release dopamine into this
area, (Section 2, 2.A), it was concluded that amphetamine had a local
effect on substantia nigra cells, so that the release of dopamine in
this area produced their auto-inhibition, which in turn facilitated the
discharge of striatal cells (disinhibition), increasing the firing rate
in the striato-nigral pathway reinforcing the inhibition of the
substantia nigra pars compacta and also inhibiting cells in the zona
reticulata, (l29), (Fig. 5).
It was also reported that pretreatment with AMPT (intraperitoneally)
reduced/
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reduced or abolished the depression of the neuronal firing rate of
substantia nigra cells, by local infusion of amphetamine, (l29, 130 -
rats) .
In an attempt to destroy the striato-nigral pathway, electrolytic
lesions were done during the recording of nigral cells; these lesions
included the crus cerebri and "the anterior border of the substantia
nigra, invading both pars compacta and pars reticulata", (130), in
these cases the local infusion of amphetamine did not have the usual
depressant effect. It was concluded that somehow the lesion
interrupted the release of dopamine in the substantia nigra, (l30).
Pig.5 HYPOTHETICAL REPRESENTATION OP THE PEEDBACK PATHWAY. (l29).
See Section 3.3. A = amphetamine site of action.
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An answer to the first report of Groves et al (l29), came a year
later by Bunney and Aghajanian (42), indicating that local anaesthetic
effects could not be ruled out with an infusion of amphetamine into the
substantia nigra, even although Groves et al (l29) had emphasized
that local anaesthetic effects were not observed, since the amplitude
of the spikes remained the same. It was also reported this time, that
lesions in the crus cerebri or in the tail of the striatum, immediately
before the intravenous injection of amphetamine usually "attenuated"
the effect although some cells had a "partial depression" in the
firing rate even at low doses (0.8 - i.6 mg/kg). It was also reported
that chronic lesions in the crus cerebri, instead of the acute lesions
they always performed, in some cases "return the ability of amphetamine
to depress" these cells. Since the effect of amphetamine in some
occasions was partial, an incomplete lesion or an action on
dopaminergic autoreceptors was given as an explanation.
Last year, the two points of view were finally united by
Aghajanian and Bunney (2) with what can be considered a good conclusion
from the electrophysiological evidence available so far: "... It is
evident both from the biochemical and physiological studies, that
feedback mechanisms involved in the regulation of dopamine neurons
are far more complex than originally supposed....The apparent
existance of presynaptic dopamine receptors and their possible role in
local feedback regulation must now be considered along with feedback
mechanisms involving neuronal circuits and modulation of impulse
flow...." (2, pag. 6).
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4. DOES THE FEEDBACK PATHWAY EXIST?
After reviewing the" literature about the feedback pathway, if a
it
person is not thoroughly confused,!is probably because he does not know
much about it. There are so many controversial reports that one begins
to think that some must be reporting artefacts. As the techniques are
improved and the ideesmodified, so are the results of the experiments.
When the hypothesis of the feedback was first proposed, evidence
to support it rapidly appeared. The anatomy indicated that the two
pathways existed (Section l), the increase in dopamine turnover after
antipsychotic drugs was verified by different techniques and opposite
effects were observed after dopamine agonists, (Section, 2.A). Also,
antipsychotic drugs and dopamine agonists were found to increase and
decrease the firing rate of dopamine cells respectively, (Section 3.E).
All giving strength to the feedback hypothesis. When it appeared
convincing that there was a feedback control of dopamine metabolism,
reports indicating that another kind of control also existed started
to emerge, and the results began to look confusing.
For instance, using anterograde and retrograde neuroanatomical
tracing techniques it was confirmed that the striato-nigral pathway did
not end directly onto dopamine cell bodies, (Section l.A), however,
this did not upset the idea of a feedback as much as the biochemical
results. In vitro studies showing that antipsychotic drugs have the
same effects as invivo, and the paradogic increase in dopamine after a
lesion of the nigro-striatal pathway (Section 2.B.2.1) are perhaps the
strongest evidence against the feedback, since the hypothesis predicted
opposite effects.
Electrophysiological results complicated the picture as well.
Dopamine/
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Dopamine cells were inhibited by direct application of dopamine or its
agonists, (Section 2«D; 3.C.l), and release of dopamine within the
substantia nigra was demonstrated, (Section 2.D) indicating that
antipsychotic drugs could also act presynaptically.
It has also been shown that other areas of the brain (e.g. locus
coerule us, hippocampus) respond in a similar way to transmitter agonists
or blockade of impulse flow, even though no anatomical evidence exists
of a feedback loop of the kind postulated for the dopamine system,
(256, 34).
As controversial evidence was gathering also alternative
explanations to the feedback were offered, for instance, it was
proposed that the regulation of dopamine metabolism takes place in the
presynaptic terminal mediated by presynaptic receptors and the
consequences of depolarization such as the influx of calcium across
the membrane (Section 2.B.2.3). Local circuits within the striatum
(Section 2.C) or the substantia nigra, (Section 2.D) have been also
proposed as regulators of dopamine metabolism. However, none of the
alternative hypothesis proposed so far, can explain all the controversial
results by themselves, and the experiments which support them are not
always consistent (Section 2.E; 3.f).
Perhaps because the idea of a feedback control was so clear when
it was first proposed, it is very difficult to see that it may not in
fact exist, and the evidence against it has found opposition. Another
reason for not abandoning the idea of a feedback loop could be that the
alternative hypothesis is not that convincing. However, since the
feedback hypothesis has lost strength, even its most tenacious
defendants/
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defendants are now proposing that besides the feedback there may be
another way of control of dopamine synthesis (52, 2).
The conservative point of view is now prevailing, it is considered
that the feedback hypothesis still can be supported but for those
cases where the hypothesis does not predict the results, .other
explanations are elaborated ad hoc.
It has been shown that the striatum and the substantia nigra can
regulate their synthesis of dopamine if left without any communication
from each other. This may be related to the "recovery of function"
commonly observed in the nervous system, (l83). In other words, an
animal even with an extensive destruction of its brain can recover
skills temporarily lost after the lesion, perhaps because the brain has
more than one system like the dopamine one which can regulate itself
even though its connections are interrupted.
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BIOCHEMICAL ANALYSIS OF THE STRIATUM AND THE SUBSTANTIA NIGRA AFTER A
LESION II THE STRIATO-NIGRAL PATHWAY.
A. INTRODUCTION.
The feedback hypothesis could not have existed if the anatomy had
not confirmed that there were fibres interconnecting the striatum with
the substantia nigra, (Chapter I, Section l). Since the striato-
nigral and the nigro-striatal pathways run close together, it seemed
very difficult to make a lesion in one pathway without damaging the
other. Early attempts to demonstrate that this interconnection was
responsible for the control of dopamine synthesis, involved a hemisection
of the brain between the striatum and the substantia nigra, (200), which
would certainly damage both pathways.
The development of techniques involving transport of material
anterogradely or retrogradely in the neurons, has helped to trace both
pathways (Chapter I, l.A). Studies of the anatomy of the striato-
nigral pathway in this way done in our laboratory by Tulloch et al (282)
have confirmed that it is wholly contained within the crus cerebri at
the level of the hypothalamus, well separated from the nigro-striatal
pathway. It occurred to us that placing a small lesion in the crus
cerebri at this level, offered the possibility of opening the so called
feedback loop and in this way evaluating the action of the striato-
nigral pathway in the control of dopamine metabolism.
It has been shown that hemisections (200) or lesions in the striatum
or globus pallidum (l69, 200) produced a decrease in Gama-amino-butyric-
acid (GABA) in the substantia nigra and also that Glutamic acid
decarboxilase/
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decarboxylase (GAD) activity is reduced in this area after lesions in
the crus cerebri (ll7, 236), (Chapter I, Section D.l). In the
experiments reported here it was decided to measure GAD and GABA in
order to determine if these fibres contain GABA. Since during the
course of this experiment, the concentration of Substance P (SP) was
reported to decrease in the substantia nigra after lesions in the
striatum and globus pallidum (ll7, 236) we decided to measure its
concentration after lesions of the fibres running in the crus cerebri.
It has been reported that the afferent fibres to the substantia
*
nigra coming from the striatum run close together with the afferent
fibres from the globus pallidum (Chapter I, Section, l.A). Therefore
a lesion of the afferent pathway willcfemage both fibre systems and
will not differentiate between the effects of each structure. Kainic
1, a neurotoxic which has been shown to damage cell bodies
Le sparing afferent terminals and axons of passage,(262),was
;cted into the globus pallidum in order to find out if that structure
le was responsible for the decrease observed in GAD activity.In this case
the fibres of the striato-nigral pathway, should be left intact while
the cells giving rise to the pallido-nigral pathway are damaged.
The results reported in this Chapter suggest that these lesions
in the crus cerebri do in fact spare the dopamine containing fibres of
the nigro-striatal pathway and deplete the substantia nigra of GABA and
SP. No effect on dopamine metabolism in the nigro-striatal dopamine
neurons was observed, supporting the idea that the striato-nigral pathway




The animals were lesioned in the crus cerebri, allowed to recover
for a week, tested for turning behaviour and sacrificed at least a
week later. The tissue was dissected and the biochemical determina-
tionswere done. Then the groups were selected according to A) the
extent and placement of the lesions indicated by the histological
analysis, or B) the drugs administered to the animals before their
sacrifice. In the pharmacological experiments the histological
analysis was done for each animal in the group and the extent of the
lesion was kept constant by discarding those rats with incorrect
f
lesions.
The mean number of the concentration of a particular chemical or
the activity of an enzyme for the control and experimental conditions




Male albino wistar rats which weighed between 190-210g at
operation were used. The animals were initially anaesthetized by
circulating an. air/fluothane mixture through a plastic box. Once the
flexor reflexes were lost, the rat was transferred to a David Kopf
stereotaxic frame where the anaesthetic was administered through a mask
fitted over the nose and mouth. The rat was maintained- at 37'C by
warming under the abdomen with an homeothermic blanket (24, A. Epil).
The skull was exposed by a sagital incision in the skin^the overlying
periosteum was scraped away and a 3 mm hole was burred with an electric
drill (Renda, England).. The tooth bar of the frame was fixed at -2.5mm
below the ear bar zero.
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Cl.l ELECTROLYTIC LESIONS.
A bipolar electrode made of twisted teflon-coated Tungsten wire
(Phoenix Wire Co.) 0.16 mm in diameter, insuMed except for the tip,
was lowered into the brain at the following co-ordinates, aiming for the
ventro-medial crus-cerebri at the level of the hypothalamus.
According to the Koning and Klippel atlas of the rat brain, (l74):
Antero-posterior: +3.7
Lateral: -2.4
Vertical: -7.8 Dura Membrane as reference point
A current provided by a 6v battery measured with an ammeter
connected in series, passed through the electrode for a period of time
such that an electrolytic lesion was always made with a total charge of
6m Coulombs, independently of changes in resistance.
Afterwards the electrode was removed, the surface of the skull
sprayed with an antibiotic powder (Polybactrin, Calmin Ltd.), and the
skin sutured"with cotton thread.
For lesions involving the whole crus cerebri, the electrode was
inserted at an angle of 46' at the following co-ordinates, (l74), with
the same reference points as above:
Antero-posterior: +3.7
Lateral: -7.7
Vertical: -6.5 and -7.5 Dura membrane as reference point.
In order to make a bigger lesion, current passed at tco different
heights 1mm appart, 6m Coulombs being delivered each time.
CI. 2/
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CI. 2 KAINIC ACID INJECTIONS.
Kainic Acid (Sigma 5mg/ml) was dissolved in saline 0.9(w/v) and
the pH adjusted to 7.4. A needle for cartridge syringes, gauge 30,
0.46mm diameter, was lowered into the brain at the following





The volume injected was 0.1 p.1 (0.5p.g) over a period of 2 min.
The needle was left in jSace for further 5 min after the injection to
allow diffusion to take place.
C2 POST-OPERATIVE OBSERVATIONS.
The animals were allowed to recover for a week. During this
period attention was payed to any loss in weight and to the regular
ingestion of food and water; if necessary, a special diet of milk
and bread was provided.
After a week, their ability to display turning behaviour (Chapter IV
Section Cl.l) was tested after an intraperitoneal injection of
apomorphine hydrochloride (Macfarland Smith Ltd., Edinburgh, 2 mg/kg).
Rats which turned 100 times or more in 30 min were considered as
having a successful lesion. In this way they were selected for their
different treatments, and the exact location of the lesion was verified




C3.1 DISSECTION OF TISSUE.
At least one week after the apomorphine test, the rats were killed
by cervical dislocation with a strong and rapid strike on the back.
Immediately, the animals were decapitated and brains rapidly removed
and placed in cold saline, (9i° w/v).
The dissection was performed over ice. The brain was placed on a
plate specially designed to hold a pair of blades approximately 1mm
apart, (Fig. 6). A coronal section behind the mammilary bodies was
cut with these blades. The piece of tissue was placed flat on a
dissection plate and a rectangular piece containing the interpeduncular
nucleus was dissected. The two substantia nigra nuclei were removed
by withdrawing the overlying cortex and making an oblique cut at the
level of the medial lem niscus on each side.
With the rest of the brain, a coronal section was made at the level
of the opticchiasma. The posterior portion was kept for histology and
the striatum was removed from the anterior part. First the nucleus
accumbens was cut and then with curved forceps the striatum was taken
out until the fibres of the corpus callosum were exposed. The frontal
piece was also kept as control tissue.
The pieces of tissue were wrapped in labelled aluminium foil and
frozen in liquid nitrogen. The freezing procedure was randomized and
the whole dissection did not take more than 5 minutes. The samples
were kept in liquid nitrogen until required for biochemical assay.
C3.2 DETERMINATION OF DOPAMINE CONCENTRATION.
The radiometric method described by Palkovits et al (23l) was





Tissues were homogenized in 0.1 N perchloric acid, (AnalaR, BDH
Chemicals Ltd.), 300 pil/lOmg of wet tissue for the striatum, and 300
pil/50mg of wet tissue, for the substantia nigra. This is to keep the
homogenates between the range of detection of the assay, 5-100 pig
dopamine/g tissue.
After centrifugation, 300 pil of the supernatant were transferred
to 15ml glass stoppered centrifuge tubes in duplicate for each sample,
on an ice bath.
Standards of 25ng of Dopamine in lOpil of distilled water were added
to another set of tubes with 30Qnl of brain extract. Blanks were
prepared by adding 300pil of perchloric acid to a third set of tubes.
The reaction was initiated by addition of lOQul of the incubation
mixture containing the following components: 500 pig of dithiothreitol
(Sigma); 0.5 pimoles of magnesium chloride; 140 jomoles of tris
(hydroxymethyl) - methylamine buffer, pH.9.6; 1ml of catechol -0-
methyltransferase (prepared from rat liver by the method of Coyle and
Henry, 603), and 2.5 P-Ci of ( H) methyl-S-adenosyl-methionine,
(specific activity: 12.6 Ci/mM - Radiochemical Center Ltd).
The reaction mixture was incubated for 60 minutes at 37'C, and was
stopped by addition of 500pil of 0.5 molar Borate Buffer, pH 10. After
the addition of 50 pil of a non-radioactive carrier solution containing
7 pig of methoxytyramine; 3 ng of normetanephrine (Sigma); 3pig of
metanephrine (Sigma) and lg of ethylenediaminetetra (BDH Chemicals Ltd.);
the O-methylated products were extracted into 9ml of water-saturated
ethyl acetate-methanol (lO:l, v/v), by shaking for 30 sec. The phases
were separated by centrifugation (200 x g force) for 2 min. As much as
possible of the organic phase was transferred to another tube. In this
occasion/
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occasion 50Q,ul of 0.5 M boric buffer, pH 10, were added. After the
tubes were shaken for 30 sec and centrifuged for 2 min., the organic
phase was transferred to another set of tubes containing 50Qul of 0.1N
hydrochloric acid, into which the O-methylated products were extracted
into the aqueous phase by shaking for 30 sec,, The phases were
separated by centrifugation and the crgari? phase aspirated and dis¬
carded. The acid phase was washed with additional 2ml of water-
saturated ethyl-acetate; after mixture and centrifugation, the
ethyl-acetate was aspirated off and discarded. To the remaining
phase, 500 ;ul of 0.5 M sodium phosphate buffer, pH 7.5 were added and
the tubes were transferred to an ice bath.
To separate normetanephrine from methoxytyramine the side chain
of normethanephrine was adhered to the beta-hydroxyl position with
50yil of a freshly prepared 3$ (w/v) sodium methaperiodate solution.
Three minutes after the addition of this solution, 5Qhl of 10$ (v/v)
glycerol were added to stop the reaction. The (%)-methyl-vanillin
derived from the cleavage of the normethanephrine was extracted into
10ml of toulene by mixing for 30 sec. After the tubes were centrifuged,
9.5ml of the organic phase can be transferred to another tube for the
determination of noradrenaline, but since in this study only dopamine
was taken into account, further details will not be included.
The aqueous phase left in the tubes after discarding the toulene
was washed with another 5ml of toulene. After mixing and centrifuging,
the organic phase was aspirated off and discarded, and 500,ul of 1.0
M borate buffer, pH 11, and 6ml of toulene-isoamyl alcohol (3:2, v/v),
were added to each tube. The (^H)-methyl-methoxytyramine was
extracted into the organic phase by mixing and centrifuging. 5ml of
the/
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the organic phase were transferred to a scintillation vials containing
10ml of NE-260 Scintillant, (Nuclear Enterprises Ltd., Edinburgh).
The samples were counted in a Liquid Scintillator, (Nuclear
Chicago), for 1 min. The results were expressed in ug of dopamine/g
of wet tissue.
C3.3 DETERMINATION OF 5.4-DIHYDROXYPHENYL-ACETIC ACID (DOPAC) AND
HOMOVALLINIC ACID (HVA) CONCENTRATION
This assay is based on the formation of hexafluoro-iso propyl
esters and their estimation by gas-liquid chromatography (GLC), combined
with electron capture detection.
The method was described by Pearson and Sharman (234) an<l modified
in our laboratory by Nicolau (214).
The samples were homogenized in 0.4 N Perchloric acid (BDH Chemicals
Ltd., AnalaR), mixed for 45 sec and centrifuged at low speed for 4 min.
The supernatant was transferred to an eppendorf tube (Eppendorf,
Germany) containing approximately 0.5g of potassium chloride, with
which the perchloric acid forms potassium perchlorate plus hydrochloric
acid. The HVA and DCPAC will attach to the acid and remain in the
supernatant. The samples were kept on an ice bath.
After shaking and centrifuging, the supernatant was transferred
to another set of eppendof tubes containing 0.5 ml of toulene in order
to eliminate the lipids. After shaking and centrifuging, the toulene
was aspirated off and discarded. This procedure was done twice. In
order to precipitate remaining proteins, the tubes were closed and left
in liquid nitrogen for 10 min. After freezing the pressure inside
was equalized by opening the cap for a moment, afterwards the tubes
were/
73.
were closed again and centrifuged for 4 min. The supernatant was then
transferred to another set of tubes containing 0.5ml of ethyl acetate.
After shaking and centrifuging, the supernatant was transferred to a set
of glass vials containing 0.5ml of ethyl acetate. The samples were
shaken and centrifuged for 4 min and left to dry completely under a
stream of dry nitrogen at room temperature. This ethyl acetate
extraction procedure was performed three times for each sample. In all
instances the samples were evaporated to dryness under nitrogen.
To each glass vial, 200p.l of trifluoroacetic anhydride (Aldrich
Chemical Co. Ltd.), and 100,ul 1,1,1,3>3>3?-Hexafluoropropan-2-ol
(BDH Chemicals Ltd.), were added. This produces an ester with HVA
and DOPAC which has a boiling point lower than these two products, and
therefore can produce a vapour containing them. The fluoride ions
provide more eletrons and increase the sensitivity of the electron
capture detector in the GLC.
Each vial was closed tightly, mixed for 5 sec and left in a plate
at 115'C (Dri-Block-Unit 3 Griffin and George Ltd.) for one hour. The
reaction vials were allowed to cool to room temperature before opening
and evaporating the contents just to dryness -under a stream of dry
nitrogen (until a brown residue is left). To this residue 1ml of
ethyl acetate containing 0.1 }ig of pentafluorophenyl benzoate (internal
standard) was added. The contents were shaken for 30 sec and trans¬
ferred to the vials used in the GLC.
The GLC fitted with a Nickel 63 electron capture detector, was
maintained at 250'C. The carrier gas was argon containing 5% methane.
It was delivered at a flow rate of 50ml/min which corresponded to a gas
pressure of 40 pounds/sq0inch. The chromatograph column consisted of
2io/
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2<f° SE liquid pha.se coated on chromosorb Q(Hewlett Packard)
The areas of the DOPAC and HVA peaks were measured in each case,
and the ratio of metabolites peak area to internal standard peak area
was calculated. These ratios were compared to those in a standard
curve, and the amounts of HVA and DOPAC in each sample were calculated,
and expressed as p.g/g wet tissue.
C3.4 DETERMINATION OF GAMMA-AMINO-BUTIRIC-ACID (GABA)CONCENTRATION
This assay is based on the formation of a derivative thought to be
1,1,1,3,3,3 hexafluoro-isopropryl-N-trifluoroacetyl-4-aminobutyrate and
its measurement by GLC and electron capture detection. The method was
described by Pearson and Sharman (233).
The tissue was homogenized in 700pl of 0-1 N hydrochloric acid.
Along with crystalline KCL, 25;nl of 12 M perchloric acid were added to
the homogenate. The sample was centrifuged at low speed for 5 min, then
25yUl of the supernatant were transferred to another set of tubes contain¬
ing 1ml of 1 M hydrochloric acid. After mixing, 0.5ml were allowed
to flow -under gravity through a chromatographic column prepared as
follows.
The resin, amberlite CG 120 (100-200 mesh; BDH Chemicals Ltd.)
was first cleaned by stirring in 2 M hydrochloric acid, washing
several times with water. After repeating this procedure three times,
the resin was poured to a depth of 2 cm into a Pasteur pipette fitted
with a glass filter at one end to retain the resin. Prior to
application of the homogenates to the column, 2ml of 2 N sodium
hydroxide solution was passed through the resin followed by 3ml of
water. Then 2ml .of 1 M hydrochloric acid were passed through
column/
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column and the resin was finally washed with 10ml of distilled water.
Once the hydrochloric acid containing the tissue sample was
allowed to flow through the column, it was washed with 10ml of water.
GABA was removed from the resin with 2ml of 2 M NH.OH solution and
collected directly into a reaction vial.
The sample was then evaporated to dryness in a vacuum desicator
over phosphorus pentoxide. The dry residue was dissolved in 0.2ml of
trifluoroacetic anhydrid and 0.1ml of hexafluoroisopropanol were added.
The reaction vial was tightly closed and left fori h at room temperature.
The contents of the vials were then evaporated just to dryness under a
stream of dry nitrogen at room temperature. To this residue, "Iml of
ethyl acetate was added and the vials were closed and shaken, before
placing them into the GLC.
The conditions of the GLC were the same as those described for the
estimation of HVA and DOPAC (Section B3.). For each run of samples,
a standard curve for GABA was prepared, using the peak heights derived
from the known amounts of GABA. The results were expressed in ug/g
wet tissue.
C3-5 DETERMINATION OF GLUTAMIC ACID DECARBOXYLASE (GAD) ACTIVITY.
The activity of GAD enzyme was calculated by the combination of the
radiochemical assay methods of Urquart et al (289) and Drummond and
Phillips (90)., The method involves the measurement of the amount of
, 14 >
radioactive carbon dioxide evolved from L-(,l- CJ-glutamic acid on
incubation with a tissue homogenate in the presence of pyridoxal
phosphate, an essential cofactor of the enzyme. Labelled carbon
dioxide is trapped in protozol and measured by scintillation counting.
The/
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The tissue was homogenized with a homogenizing buffer (lO/il/mg
tissue) containing the following: lOpl of phosphate buffer, pH 6.5;
lOQul of 10 M pyridoxal-5-phosphate (Sigma; to form glutamic acid);
lOpil of Triton-X-100, (to emulsify the sample), and 10ml of distilled
water.
To another set of tubes, lOptl of the homogenate were transferred.
The incubation mixture contained (final concentration), 100 mM
potassium phosphate buffer, pH6„5; 0.5 mM pyridoxal-5-phosphate;
0.5 mM dithiothreitol; 1.22 mM L-(l-"^C)-glutamic acid, (specific
activity 5.5 mCi/mM) diluted with 0.5 mM unlabelled glutamic acid;
0.1 mM Triton-X-100; 1 mM sodium arcenite ahddistilled water, 10fo
(v/v).
Blanks were prepared by mixing 10pl of the homogenizing buffer
with lOp.1 of the incubation mixture. To each tube containing the
tissue homogenate, lOpil of the incubation mixture were added, and the
tubes placed into a scintillation vial containing 25Qul of protozol,
(to trap the C carbon dioxide liberated in the reaction). A rubber
seal was used to close the scintillation vial. After incubation for
20 min in a warm bath of 57'C, the reaction was terminated by the
addition of 0.2ml of 6 I Sulphuric acid injected through the rubber
seal into each eppendorf tube. The vials were left in the warm bath
14
for one hour in order to collect into the protozolthe C carbon
dioxide released. The outside walls of the eppendorf tube were then
rinsed with 2ml of absolute alcohol on their removal from the
scintillation vial. 10ml of toulene scintillant were added to the
protozol and the alcohol remaining in the vials. After a minimum of
half an hour to eliminate luminescence produced by the toulene, the
samples/
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samples were placed in the scintillation counter (Nuclear Chicago), and
the radioactivity measured for 1 min. The number of counts per min
for each sample after sub.:traction of the blank value, were corrected,
for the counting efficiency, the time of incubation, the amount of
protein present in every individual portion of the homogenate used,
in every individual assay, and the specific activity of the
radioactive glutamate in the assay.
To estimate the contents of protein in the sample, 5p.l of the
tissue homogenate were treated with the method of Lowry et al (l93)•
14
The results were expressed in nmoles of CO^ formed per mg of protein
in the sample per hour of incubation„
0,3.6 ESTIMATION OF SUBSTANCE P (SP) CONCENTRATION.
The method was described by Kanazawa and Jessell (l59). SP was
first extracted by a modified version of the procedure described by
Chang and Leeman (59) with aceton in hydrochloric acid. The SP
obtained in this way was measured by radioimmunoassay using the method
described by Powell et al (239)• Antibodies to SP formed in rabbits
and guinea pigs were incubated with the samples to be assayed for 24 hr;
radioactively labelled antigen, 125-Iodine labelled SP, was added and
the incubation continued for another 48 hr.. The antibody-bound label
was separated from label free in the incubate, by differential absorb-
tion onto charcoal and the radioactivity determined. Owing to
competition for the limited number of antigen-binding sites available,
the amount of labelled SP-bound antibody drops as the concentration of
the unlabelled antigen increases. The results obtained were compared
with standard curves obtained with samples of known content of SP. The
results/
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results were expressed in ng/g wet tissue.
C4. HISTOLOGICAL ANALYSIS
The tissue left for histological analysis was stored in a deep
freezer on a glass beaker containing ice, covered with cling film,
(C.E. Payne & Sons Ltd.)
Frozen sectiocs 20-40/m thick were cut with a Cryostat (Linde,
Germany) kept at -40'C„ The sections were melted onto a glass
microscope slide (76 x 26mm, Chance Proper Ltd.), for further staining.
C4.1 STAINING OF TISSUE.
The method used was a modified version of the Kluver and Barrera
technique (173) for staining myelinated fibres and cell bodies.
The tissue was dehydrated in 70$ alcohol followed by 95$ alcohol
both for 5 min. The slides were transferred and left for 10 min in a
95$ alcohol solution containing 1 mg/ml of Luxol Fast Blue (BDH Chemicals
Ltd.), and 5;ul/ml of 10$ solution of acetic acid. Then the slides were
rinsed in distilled water, immersed into 0.05$ (w/v) lithium carbonate
for 3 min and then placed in 70$ alcohol for another 3 min. This
procedure was repeated until clearly differentiated staining of
myelinated tracts were observed. The slides were transferred to a
solution containing 0.1a/° (w/v) cresyl fast violet (Fluka, A.G., Buchs,
S.G., Switzerland) in distilled water, and left for 5 min. Afterwards
they were rinsed and dehydrated in 95$ alcohol for 5 min and in absolute
alcohol for 10 min and cleared in Xylene (Analar) for 10-15 min.
Canada Balsam in Xylene (BDH Chemicals Ltd.) was used as a mounting
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All these drugs were administered intraperitoneally.
C6 STATISTICS.
The statistical significance of the mean values for two different
groups was estimated with the student's t-test for small samples for
equal or unequal variances according to the case, (26) ►
The t-test for paired observations (l42) was used if a group was
compared against itself, that is, the same group before and after an
experimental treatment or the comparison of values obtained on one side
of the brain against the other.
Since a direction in the difference was expected (e.g. a decreased
amount of a possible transmitter), a one tailed rejection region was used
to test the significance of the difference.




In the tables, the mean number was represented as X; the standard
deviation as G~ and the total number of observations as N.
The percentage decrease was calculated as follows: 100 - L x 100
C
where L is the value obtained for the lesioned side, and C is the
amount obtained for the unlesioned side or the control group,
specified in every case.
Eig-7 Electrolytic lesion (dotted line)
of the crus cerebri. Staining:
(Section B4-). Calibration mark:
in the VENTRO-MEDIAL AREA




Die THE ACTIVITY OF GAD AND THE CONCENTRATION OF SP MP G-ABA IN THE
SUBSTANTIA NIGRA.'' ' ' ' ' " "F "
A lesion in the ventro-medial portion of the crus cerebri typical
of the rats studied under this section is shown in Fig. 7.
A group of 10 lesioned rats showed a significant decrease in GAD
activity in the substantia nigra when compared against the substantia
nigra values of the unlesioned side of the brain or the GAD activity in
this area for a control group. A similar reduction in GAD activity
after the lesion in the crus cerebri, was also observed in the
interpeduncular nucleus, (Table i).
The concentration of GABA in the substantia nigra determined in 3
rats also showed a significant decrease in the lesioned side compared
with the unlesioned side or against the control group, (Table i).
Twelve lesioned rats on which the concentration of SP was
determined in the substantia nigra showed a significant decrease on
the lesioned side. This reduction did not produce any significant
alteration in the concentration of dopamine in the striatal and frontal
areas, (Table II). The results presented in this section are
summarized in Fig. 8.
Dl.l POST-OPERATIVE OBSERVATIONS.
After the electrolytic lesions the rats did not lose weight
during the first week after the operation and did not show any gross
alteration in its motor performance. As discussed in Chapter IV,
these rats displayed turning behaviour towards the lesioned side if
injected intraperitonealy with apomorphine, (Fig. 8).
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TABLE I




EXPERIMENTAL X 239.0 480.1

































GROUP 100$ 58.6 65.5 36.5
UNSUCCESS- X 398.8 460.1 118.3 199.8
FUL LESIONS ^ 12g<8 39,3 49.9 21.2
N
able 1. Mean values (X) of GAD activity and GABA concentrations in substantia
nigra and interpeduncular nucleus of Crus cerebri lesioned rats,
(experimental group), control group and unsuccessfully lesioned animals.
For this and the following tables:
The percentage decrease was taken using the control value
as 100$ (Section C6)





















Fig. 8 GAD activity and the concentration of SPin
the SUBSTANTIA NIGRA for lesions plotted on
diagrams reproduced from two levels from the
Konig and Klippel atlas of the rat brain, (l74).
Lower graph: behavioural observations one week





side side °/° Decrease P<
SUBSTANCE P X 94.06 194.64 51.68 0.005
(T 46.86 107.16
N 12
DA X 9.27 9.59 5.3 N.S.
STRIATUM $ 1.50 1.70
N 12
DA X 0.68 0.84 19.0 N.S.
FRONTAL G 0.20 0.28
N 12
NUMBER OF X 163-9
TURNS/30 MIN <5 74.6
N 12
D1.2 CONTROL GROUPS.
Animals with lesions in other areas around the crus cerebri
(unsuccessful lesions), like the hippocampus, amygdala, zon< incerta
and Forel's fields, did not show a significant decrease in GAD
activity or in the concentration of GABA in the substantia nigra,
compared against themselves or against a control group of unlesioned
rats, (Table i).
Fig. 9 Electrolytic lesion (dotted line) in the LATERAL PORTION
of the eras cerebri. Staining: Kluver and Barrera technique
(Section B4-). Calibration mark: lOQmn.
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D2. EXTENT OF THE LESION AMD GAD ACTIVITY IN THE SUBSTANTIA NIGRA.
Attempts to make a lesion in the crus cerebri in different places
in order to relate the extent of the lesion with the decrease in GAD
activity in the substantia nigra, produced a group of 10 rats, 3 with
lateral lesions, (Fig. 9), 3 with medio-ventral lesions (Fig. l) and 4
with all the crus cerebri destroyed.
TABLE III
EXTENT OF THE LESION AND GAD ACTIVITY IN THE SUBSTANTIA NIGRA.
LATERAL MEDIAL COMPLETE CONTROL
GROUP
L C L C L C
GAD X349.9 488.8 227.7 508.6 242.7 488.9 576.9
ACTIVITY C 17.5 51.6 82.6 72.2 93.7 122.3 112.3
N 3 5 4 4
jo DECREASE:
UNLESIONED % 28.4 55.2 50.3
SIDE A
10Of°




P k. OoOl 0.005 0.005 0.05 (against
each group)
NUMBER OF X 83.33 163.0 191.6
G 48-7 40-3 31-9




All lesions produced a significant decrease in GAD activity in
the substantia nigra of the lesioned sidecompared against the
unlesioned side or against the control group. The animals with lesions
in the medio-ventral portion of the crus cerebri showed the highest
decrease (60.5$) in GAD activity in the substantia nigra, while the
rats with lesions in the lateral portions showed the smallest decrease
(39.3$) compared against the control group, (Table III).
The animals which produced the biggest mean number of turns
(191.6) were the ones that had the largest lesion, and the rats with
lesions in the lateral portion of the crus cerebri had the smallest
mean number of turns (83.3), although the difference was not
statistically significant, (Table III)- The results of this
section are represented in Fig. 9»
When GAD activity in the substantia nigra of the control group
was taken as the 100$ in order to calculate the percentage decrease
in the groups lesioned animals, the percentage decrease was 5-10$
greater than when the GAD activity of the substantia nigra of the
unlesioned side was taken as a 100$, (Table III). This is due to a
non-significant but consistent decrease in GAD activity in the
substantia nigra also observed in the unlesioned side of the













^•control group as 100
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□ unlesioned side as100 '0
| Standard error
Pig.10 Percentage decrease in GAD activity in the
SUBSTANTIA NIGBA for lesions plotted on diagrams-
reproduced from the Konig and Klippel atlas of the
rat brain, (l74)
Lower graph; behavioural observation one week after
the lesion.
Inset: percentage decrease in GAD activity in the
substantia nigra of the unlesioned side of experimental
animals compared against the control group.
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D3. LESIONS WITH KAINIC ACID AID GAD ACTIVITY DETERMINATIONS.
Kainic acid, was injected into 5 rats, aiming for the globus
pallidum. After the histological analysis, it was found that only 2
rats had an injection circumscribed to this area, one rat had a lesion
of the nucleus ventralis and nucleus reticularis of the thalamus, and
2 rats had the injection in the striatum, one in the ventro-lateral
area, and the other in the dorsalateral area of the body of the
nucleus, (Pig.ll). Comparing the individual values, the lesions of the
body of the striatum, showed the biggest decrease in GAD activity in the
striatum, substantia nigra and frontal areas. The two lesions in the
globus pallidum also produced a reduction in GAD activity in the
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Fig.11 Percentage decrease in GAD activity in the striatum
and substantia nigra after kainic acid lesions represented
in a diagram of a longitudinal section of the brain
taken from the rat atlas, (l74).






L C L C L C
Experimental group X 8.58 9.14 1.19 1.41 1.04 1.19
<T 1.98 2.63 0.35 0.38 0.18 0.32
N 41 8 8
Control Group X 8.97 1. 09 1.14
G 2.46 0. 26 0.21
N 38 12 12
Unsuccessful X 9.35 8.82 1.52 1.35 0.99 0.96
Lesions 6 2.33 2.74 0.19 0.17 0.13 0.12




Lesions damaging the striatum or globus pallidum with kainic acid,
produced aphagia which was overcome by giving the rats a special diet
of bread and milk for three days after which they started to eat their
ordinary food. A week after the operation they showed a decrease in
weight between 50-100g compared to their weight on the day of the
operation. Afterwards they gained weight normally. The significance
of the results is discussed in Chapter IV.
D4./
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D4.. PARTICIPATIOH OF THE STRIATO-WIG-RAL PATHWAY IN THE METABOLISM
OF DOPAMINE.
Rats which had a ventro-medial lesion in the crus cerebri like the
one illustrated in Fig.7 were included in this analysis, a small number
of animals with lateral lesions (Fig.4?) were also included.
D4.1 THE CONCENTRATION OF DOPAMINE AND ITS METABOLITES HVA AFP DOPAC
IN THE STRIATUM OF LESIONED RATS.
The concentration of Dopamine, HVA and DOPAC were measured in
lesioned and control rats after apomorphine and haloperidol. The
concentration of dopamine was also determined after alph-methyl-
para-tyrosine (AMPT) and its combined treatment with haloperidol
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Pig.12 The concentration of dopamine, HVA and
DOPAC in the STRIATUM for control and
experimental lesioned rats, determined after
treatment with different drugs, (Section D4.l).
A, statistically significant compared with











Experimental X 10.38 9.17 1.05 1.
Group <s 3.19 1.69 0.08 O.i
N 8 8
Control X 9.54 0.94
Group 5 2.25 0.09
N 14 14
Control X 8.97 1.09























D4.1.1 NO DRUG TREATMENT.
Lesioned rats had a similar concentration of dopamine in the
striatum of the lesioned side compared with the unlesioned side or
compared with the concentration of dopamine in the striatum of the
control animals, (Table V).
Lesions in other areas around the crus cerebri (unsuccessful
lesions) like hippocampus, amygdala, zona incerta or Porel's fields, had




































































The concentration of dopamine in the striatum of lesioned rats
injected with apomorphine was NOT statistically significant from the
concentration determined in both striatal nuclei of control treated rats.
Neither group differed statistically from control animals which did not
receive any injection. The same results were obtained for the
concentration of HVA. The concentration of DOPAC in both experimental
and control injected animals was statistically reduced compared with
control untreated rats. (Table VI.).
D4.1.3 HALOPERIDOL TREATMENT.
Haloperidol produced a significant decrease in the concentration
of/
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of dopamine in the striatum of lesioned and control rats and a
significant increase in HVA and DOPAC, compared with control untreated
rats, (Table VIl). There was no statistically significant difference
within any of the groups, only between the haloperidol injected rats
and the control untreated animals.
D4.1.4 AMPT TREATMENT.
AMPT produced a significant decrease in the concentration of
dopamine in the striatum of treated control or lesioned animals
compared with control untreated rats. Similar results were observed
for frontal areas. (Table VIIl).
There was no statistically significant difference in the
concentration of dopamine of the lesioned side compared with the
unlesioned side of experimental treated rats or between these values
and control AMPT injected animals. These groups were statistically
different only when compared against control untreated rats, (Table VIII).
D4.1.5 COMBINED TREATMENT OF AMPT PLUS HALOPERIDOL.
The concentration of dopamine in the striatum and frontal areas
of control and experimental lesioned animals treated with these drugs,
did not differ compared among themselves, but showed a significant
decrease compared with control untreated rats or control rats injected
with haloperidol alone, (Table VIIl).
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D4.2 THE CONCENTRATION OF GABA AND THE ACTIVITY OF ITS SYNTHETIC
ENZYME GAD IN THE SUBSTANTIA NIGRA OF LESIONED HATS.
The concentration of GABA and. the activity of GAD were measured
in lesioned and control rats in conditions where no drugs were
administered or after haloperidol treatment. The concentration of
GABA was also measured after treatment with apomorphine, and GAD
activity was estimated after AMPT and its combined treatment with
haloperidol. The results summarized on Tables I, IX, and X are
illustrated on Pig. 13. In all cases the concentration of GABA and
the activity of GAD were significantly reduced in the substantia
nigra of the lesioned side compared with the control group for each
























X 5.71 6.15 0.58 0.49
6" 1.50 1.50 0.10 0.15
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Standard deviation
Fig. 13 The concentration of GABA and the activity
of GAD in the SUBSTANTIA"NIGRA for control
and experimental lesioned rats, determined
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El. ABOUT THE METHODS.
Measurements of the contents of GAL'-A in discrete brain regions using
different procedures to isolate and cool the brain, have shown that the
time elapsed between death and freezing of the tissue is crucial for the
determination of the concentration of GABA, (3, 279). In the whole brain
a 30-50^ increase in GABA content occurs in the first few minutes after
death and as much as 100$ in brains kept at room temperature for 1 hr,
(l9l). Microwave fixation has been proposed as a method to avoid such
increase, (l6), however, the time of exposure to microwave seems to be
an important variable, and the method itself increases the variance of
the results, (3).
Glutamic acid decarboxylase, (GAD), appears to be a better marker
for GABA-containing neurons, its activity correlates with the
distribution of GABA, (95, 227), it is less subject to post-mortem
changes and can be measured in small samples, (278). For this reason
GAD activity was mainly used in this study as an index of the
concentration of GABA. The concentrations of GABA were also included
because the interest of this work was to estimate a decrease in its
concentration and not its actual in vivo level or its regional
distribution within the brain.
No significant changes in the concentrations of dopamine, HVA or
DOPAC, have been found to occur if the time between decapitation and
freezing of the tissue is kept between 2-5 min, (207). The dissection
procedures as described in Section B3.1, did not take more than 5 min,
the same area of both sides of the brain was frozen at the same time and
the order in which different areas were frozen was randomized.
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E2« GABA AND THE STRIATO-NTGRAL PATHWAY.
The main purpose of this work was to make a lesion in the fibres
of the striato-nigral pathway running through the crus cerebri, (282)
without damage to the ascending fibres of the nigro-striatal pathway
in the medial forebrain bundle, (Chapter I, Section l.B). The
histological analysis indicated that the lesion was circumscribed to
the crus cerebri, and this was verified by the biochemical analysis,
since no change in the concentration of dopamine or its metabolites,
HVA and DOPAC, was observed on the lesioned side, (Table V) . Damage
to the nigro-striatal pathway has been reported to produce a
significant loss in the concentration of dopamine in the striatum, (224)
which was not observed after lesions in the crus cerebri.
Anatomical tracing studies indicated that the striato-nigral path¬
way runs mainly in the ventro-medial portion of the crus cerebri, (282).
This was corroborated with these results, since a lesion in the rest
of the crus cerebri, including only a portion of the ventro-medial part
(lateral area) only produced 39.3^ reduction in GAD activity compared
to unlesioned animals, (Table III)- This reduction was probably due to
the partial lesion in the ventro-medial area. This is supported by
the fact that a complete lesion of the crus cerebri did not produce a
further decrease in GAD activity than the one produced by a lesion in
the ventro-medial portion of the crus cerebri.
There are afferent fibres from the globus pallidum to substantia
nigra and the pathway which they follow runs very close to the site of
the crus cerebri lesion, (Chapter I, Section l.A)., therefore this
lesion will damage both pathways to the substantia nigra, the striato-
nigral and the pallido-nigral.
Although/
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Although the numbers are very small to conclude anything from the
experiments injecting kainic acid, it is relevant to note that both
striatum and globus pallidum lesions produce a decrease in GAD activity
in the ipsilateral substantia nigra- It would be interesting to verify
this in a bigger sample and also determine the concentration of SP in
the substantia nigra after lesions with kainic acid in these structures.
It is interesting that the rat with a lesion in the dorso-lateral
area of the body of the striatum had the biggest percentage decrease in
GAD activity. This is an area which projects mainly to the intermediate
portion of the pars reticulata of the substantia nigra, in the rat, (43).
It is relevant to point out that after kainic acid lesions in the
striatum there seems to be an increase in GAD activity in the contra¬
lateral substantia nigra, if the values are compared against the
control group, (Table IV). Since the GAD activity values for the
control group and the lesioned animals were not estimated at the same
time, there is the possibility of inaccuracy of the biochemical assay,
however, this does not seem to be the case, since the GAD activity for
the substantia nigra of the intact side of thalamic and globus pallidum
injected animals falls within the range of the control values. The
increase in GAD activity in the contralateral substantia nigra suggests
that there is a relation between the striatum and the substantia nigra
on both sides. A connection between the two striatum had been reported
in rats, with horseradish peroxidase injections, (205). This connection
is one of the many pathways which can be proposed to relate the
structures on both sides. Lesions of the crus cerebri produced a non¬
significant but persistent decrease in GAD activity on the substantia
nigra of the intact side, (Table III, Fig.10 inset). This again
agrees/
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agrees with the stiggestion that somehow both nigral nuclei must be
interconnected. It has also been found that dopamine formed from
radioactive tyrosine collected from both substantia nigra nuclei change
in opposite directions, (215, 219, 216). An influence of one
substantia nigra to the other can also be mediated through the nigro
thalamic, thalamo cortical projections and from the cortex to both
striatum which send afferents back to the substantia nigra, (54).
Eo3 DOES THE STRIATO-NIGRAL PATHWAY PARTICIPATE IN THE METABOLISM
OF DOPAMINE?
It has been repoi-ted that after antipsychotic drugs (e.g.
chloropromazine and haloperidol) the concentration of dopamine is
significantly reduced and the levels of its metabolites (e.g. HVA)
are increaseh(6, 155). Opposite effects are reported after treatment
with dopamine receptor agonists (e.g. apomorphine) where although the
concentration of dopamine remains unchanged the levels of HVA are
reduced, (253). This has been taken as a strong evidence in favour
of the feedback hypothesis. The fact that the blockade or stimulation
of dopamine receptors have opposite effects led to the conclusion that
the feedback originates from the postsynaptic dopamine receptor
activity (Chapter I, Section 2.A).
Haloperidol treated rats to which AMPT was also given showed a non¬
significant tendency towards an acceleration of dopamine loss. This
was explained by a negative feedback mechanism due to postsynaptic
receptor blockade, (6).
The results reported here (Section D.4.1; Pig. 12) mainly confirm
these observations. The only discrepancy found was that the
—concentration/
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concentration of HVA was not significantly reduced after apomorphine,
although the concentration of DOPAC was. This may be due to
difference in dosage: 25mg/kg subcutaneous, 45 min before death (255),
against 2mg/kg, intraperitoneal, 30 min before death used in this
experiment. A similar decrease in DOPAC has been reported, (l45).
The relevance of this experiment lies in that even animals with
lesions of the striato-nigral pathway whose activity was supposed to be
sponsible of the observed effects,showed changes in the same direction
as control unlesioned rats.
It can be argued that the lesion was not complete and that activity
of the fibres left intact is responsible for the results. However
comparisons of the lesion site with the anatomy of the striato-nigral
pathway (282) suggests that the lesion clearly damages the area where
these fibres are contained.
The activity of GAD or the concentration of GABA was estimated in
every drug-treated group (Section 4.2, Pig.13) and the histological
analysis was done for every animal in order to determine the extent
of the lesion. In every case the decrease in GAD activity or in the
concentration of GABA was significantly reduced compared to unlesioned
rats, and the lesion was found in the ventro-medial area of the crus
cerebri.
Alternative explanations for the control of dopamine metabolism
have already been discussed (Chapter I, Sections B.2.3.; C.l and D.l).
The results of this experiment cannot give direct support to any
of them but agree with the generaly idea that other explanations for
the effects of antipsychotic drugs and dopamine receptor agonists, on
dopamine metabolism, must be sought.
A/
110
A report in agreement with this suggestion has been put forward
recently. It has been shown in the rat, that after a lesion of the
striato-nigral cells with kainic acid, the systemic administration of
haloperidol increases and of apomorphine decreases DOPAC levels equally
in both control and lesioned animals in the striatum, (62). This
indicated that an action at the level of the post-synaptic dopamine
receptors is not a pre-requisite for the effects of these drugs.
It has been reported that radiofrequency lesions in the striatum
and globus pallidum produce not only a decrease in GAD activity but also
in the concentration of SP, (l60). Lesions interrupting the fibres
from these nuclei to the substantia nigra, confirm these results,
(Table II), suggesting that this fibre system includes SP-containing
fibres as well as GABA containing ones.
Recently, release of SP has been observed in vitro from the
substantia nigra, (l53). An interaction between GABA and SP teiminals
is proposed, since addition of GABA to the superfusion media inhibited
the release of SP, (l53)» However, the role of SP in the substantia
nigra remains to be studied.
Since lesions of the striato-nigral pathway reduced the concentration
of GABA as well as SP, it is not likely that SP is involved in the
control of dopamine metabolism. SP and GABA could be involved
respectively in the excitatory and inhibitory responses recorded from
cells in the substantia nigra after stimulation in the striatum. SP
and GABA could be mediating different kinds of output from the striatum
to thalamus via the substantia nigra, since substantia nigral cells in




The feedback hypothesis predicted that antipsychotic drugs
blocked dopamine receptors on GABA containing neurons in the striatum
producing a decrease in the concentration of GABA in the substantia
nigra relieving dopamine cells from inhibition. Dopamine cells in turn
according to the hypothesis would increase their activity and the
synthesis of dopamine giving as a result that significant increase in
dopamine metabolites in the striatum observed after antipsychotic drugs.
However, against prediction the decrease in the concentration of
GABA and in GAD activity observed after lesions in the striato-nigral
pathway, does not intervene in any way in the response produced by
dopamine cells to haloperidol or apomorphine.
A strong evidence in favour of the participation of GABA according
to the feedback hypothesis, was the reduction of haloperidol induced
activation of TOH in the striatum after injection of GABA agonist,
muscimol, in to the substantia nigra, (l35)• However, since this
experiment involved an injection directly into the substantia nigra
through an implanted cannula., damage to nigral cells could account for
the results.
Apart from the so-called striato-nigral pathway, there are at least
two other pathways from the striatum to the substantia nigra which could
be involved in a feedback loop. One involves the tail of the striatum,
(282, 43). This pathway has been shown to travel lateral to the pathway
from the body of the striatum, (282), lesions of the crus cerebri in this
area, (lateral lesions, Fig.9), interrupt these fibres without effect
on dopamine metabolism measured by the concentration of HVA and DOPAC in
the striatum with no drug treatment or after haloperidol or apomorphine
—administration, (D.4«1)» Therefore, the participation of this pathway
is/
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is eliminated. Another possible pathway involves connections from
the striatum to the subthalamic nucleus and from there to substantia
nigra, (140). The participation of this pathway can be also excluded,
since lesions of the crus cerebri in several cases included the
subthalamic nucleus without any effect on dopamine metabolism.
P. SUMMARY.
I. It was observed that lesions of the striato-nigral pathway in the
ventro-medial portion of the crus cerebri produced:
A - In the striatum of the lesioned side:' No change in the
concentration of dopamine, HVA and DOPAC. Indicating
that the nigro-striatal fibres were not damaged.
B - In the substantia nigra of the lesioned side: A
significant decrease in the concentration of GABA,
in the activity of GAD and in the concentration of SP.
C - In the substantia nigra of the unlesioned side: A non¬
significant but consistent decrease in GAD activity.
II. A lesion of the striatum and of the globus pallidum with kainic
acid also produced a significant decrease in GAD activity in the
ipsilateral substantia nigra.
III. Drug Treatment: In the striatum of control and lesioned animals:
A - Apomorphine produced a significant decrease in the
concentration of DOPAC.
B - Haloperidol produced a significant increase in the
concentration of HVA and DOPAC and a significant
decrease in the concentration of dopamine.
It/
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It is suggested that the striato-nigral pathway is not involved
in the control of dopamine metabolism.
CHAPTER III
ELECTROPHYSIOLOGY OF THE SUBSTANTIA NIGRA PARS COMPACT AFTER
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ELECTROPHYSIOLOGOY OF THE SUBSTANTIA NIGRA PARS COMPACTA AFTER
A LESION IN THE STRIATO-NIGRAL PATHWAY
A. INTRODUCTION.
Strong support for the feedback hypothesis came from electrophysio¬
logical experiments, (Chapter I, Section E.3.2). However, not all the
results agree with the hypothesis. Iontophoretic administration of
apomorphine onto the substantia nigra cells in the pars compacta
decreases their firing rate, (l) and direct microinfusion of amphetamine
also has a depressant effect on these cells, (l29). This suggested
that these drugs when injected intravenously were having both a direct
and indirect effect. That is they were acting in the striatum but also
in the autoreceptors of substantia nigra cells, (Chapter I, Section E.3.
2). It seemed that one way of finding out if activity of striatal
cells sending efferents to the substantia nigra were involved in the
response to drugs, was to make a lesion of the striato-nigral fibres
and test the response of dopamine cells to drugs. However, in the
experiments reported in the literature so far, the extent of the lesions
seemed to affect in one way or another the dopamine cells, (40, 42, 130).
Since the results presented in Chapter II showed that our lesions do not
affect the biochemical response of dopamine cells of the substantia nigra
it was decided to make a localized lesion in the striato-nigral pathway
in order to test the effect of the intravenous administration of
amphetamine and haloperidol on cells in the substantia nigra pars
compacta.
The results reported here suggest that lesions of cells in the
—striatum with kainic acid or electrolytic lesions of the striato-nigral
pathway/
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pathway do not prevent the effect of amphetamine or haloperidol except
when the lesion extends to the substantia nigra. In order to give
further evidence, partial lesions of the substantia nigra pars
compacta were made with 6-hydroxydopamine. In this case the effects
of the amphetamine on the remaining intact cells were also prevented.
This suggests that all dopamine cells must be intact in order to
observe the decrease in the firing rate produced by the administration
of amphetamine, whereas efferent fibres from the striatum do not
mediate this response.
B. PROCEDURE.
Rats were lesioned in the striatum or in the striato-nigral path¬
way, allowed to recover for a week and tested for turning behaviour.
The recording experiment was done 10-15 days after the lesion. In
some occasions a stimulating electrode was implanted before the
recording to attempt to identify the cells antidromically.
Other rats were lesioned acutely during the recording experiment in
which case they did not have any previous treatment.
Only one cell was recorded per experiment to avoid the residual
effect of drugs. The firing rate of the cell was tape-recorded and
plotted on paper. After a control period, amphetamine was injected
intravenously, later, in some cases, haloperidol was administered
followed by a second injection of amphetamine.
At the end of the recording, pontamine blue dye was ejected from
the tip of the electrode to identiy the recording area. Then the
—animals were sacrificed and the brain removed for histological analysis.
-C. METHODS.
The procedure for the stereotaxic surgery and the electrolytic
^Lesions/
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lesions has been described in Chapter II, Sections, C.l, C.l.l.
C.l KAIN1C ACID INJECTIONS
This procedure has been described in Chapter II, Section C.l.2,
except that the co-ordinates in this case were aiming for the striatum.




With the surface of the dura membrane as the reference point for the
vertical co-ordinate.
C.2 6-HYDR0XYD0PAMINE (6-OHDA) INJECTIONS
6-OHDA, (Hassle, Biotec) 1.25mg/ml was dissolved in saline, 0.9%
(w/v) containing 1.0mg/ml of ascorbic acid, and the pH was adjusted to
7.4.
A stainless-steel needle, for cartridge syringes, gauge 30,
0.46 mm in diamter was lowered into the brain ailing for the fibres in




The volume injected was 4 nl over a period of 5 min. To allow
for diffusion, the needle was left in place for further 5 min.
C.2.1 BIOCHEMICAL ANALYSIS.
In order to determine the extent of the 6-OHDA lesion, the
concentration of dopamine in the striatum was determined with the assay
described in Chapter II, Section C.3.2.
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C.3 POST-OPERATIVE OBSERVATIONS:
These were the same as described in Chapter II, Section C.2, except
that the dose of apomorphine administered intraperitoneally to the
6-OHDA lesioned animals was 0.2 mg/Kg. To select rats which only had
a partial lesion of dopamine cells, only those which turned after being
handled and not more than 30 times in 30 min were selected for the
recording experiment.




The rats weighted between 210-250g at the time of the experiment.
They were anaesthetized as described in Chapter II, Section C.l.
Once the flexor reflexes were lost, a tracheostomy was performed and a
glass tracheal cannula fixed, through which the anaesthetic fluothane/
air mixture was delivered from then on at a rate of 1.5$ 300m/min until
the beginning of the recordings, when the rate was lowered to 0.7$.
If the tracheal cannula blocked during the experiment, it was cleared
by suction with a plastic cannula and a syringe. Once the neck wound
was closed the rat was placed on a homeothermic blanket, (240 Epil),
maintained at 57"C, and fixed to a David Kopf stereotaxic frame. When
a blood pressure recording was done, the femoral artery was cannulated,
the cannula (Portex, O/D 0.5mm) was flushed through with 5.000 u/ml
Heparin (Evens) solution and filled with 1:1000 u Heparin solution.
As suggested in the literature, (lOO, 103, 43) the recording
electrode was introduced into the brain at an angle of 46' from the
vertical line to ensure that the electrode lies along the
longitudinal axis of the substantia nigra, increasing the possible
-number of cells available for recording, (Fig. 14).
On the recording side the temporalis muscle was pushed away from
-the skull. The stereotaxic co-ordinates, (174) aiming for the
■substantia nigra pars compacta were:
Antero-Posterior: +2.3
Lateral: -6.8 to -7.2 (according to the
weight of the rat)
Vertical: -6.0 to -8.0
The co-ordinates were measured using a fine pin placed instead of
—he/
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the microelectrode. A hole approximately 3mm in diamter was bored
for the recording electrode. In order to leave the cortical surface
intact, a microscope at low magnification was used during this
procedure, and a thin piece of bone was left to be removed with fine
forceps. Then the dural membrane was ruptured with a small needle
and lifted to the side with forceps. The exposed cortex was bathed
in warm liquid paraffin to prevent drying of tissue. A drawing of
the exposed cortical surface was made indicating the area where the
electrode had to be placed.
C.4.2 IMPLANTATION OF ELECTRODES.
In some occasions an electrode for stimulation or lesioning, was
implanted. It was made of twisted stainless steel wire, 0.16 mm in
diameter and insulated except for the tip.
The stimulating electrode aiming for the fibres of the medial fore-
brain bundle was placed using the co-ordinates described in Chapter II
Section C.2. The electrode used for lesioning was placed in the
ventro-medial portion of thb crus cerebri using the co-ordinates
described in Section C.l.l.
The electrode was fixed to the skull with dental acrylic (Howmedica
Internal. Ltd.). To provide support a nylon screw (Walker-Spencer
Component Ltd.) was inserted into a hole drilled in the skull at the
level of the lambda suture.
C.4.3 MICROEbECTRODES.
A theta style cappilLary glass micropipette, (TGC 150, Clark
Electromedical Instruments) was used for making the microelectrodes.
The glass was pulled with an electrode puller (Forth Instruments Ltd)
■and/
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and the microelectrodes were filled using a syringe and a long fine
needle with pontamine sky blue (Gurr, Ltd.) made up as a 2i° solution in
0.5 M sodium acetate. The solution was filtered through a medium fast
paper filter, (Qualitative No. 1, Whatman), and the pH adjusted to 7-7.
The resistance was determined "using the method whiah relies on
generating a constant current signal that produces a voltage across the
microelectrode, proportional to the electrode resistance, ( 37).
Microelectrodes having a resistance of 10-20 megaohms were used.
The electrode held in' a special adapted David Kopf electrode holder
was placed in position with the help of the microscope. A small
stepping motor, (Forth Instruments Ltd.) fitted into the holder
connected to a microdrive was used to advance the electrode by 2pim
steps.
C.4.4 RECORDING SET UP.
4.4.1 RECORDING OF CELLS.
The electrode was connected to the gate of a field-effect
transistor (PET No. 2N3819, R.S. Components Ltd.) used as a voltage
follower, by means of a silver/chloride wire. The voltage for the
FET came from two 6 V batteries connected in series. The output of
the source was connected to a differential amplifier (5A22N; Tektronix)
of a dual-beam storage oscilloscope (D.13, Tektronix). The reference
point was provided from the indifferent electrode made of a silver/
silver chloride wire inserted into a neck muscle. The bandwidth of
the amplifier was set at 1.0-10.0 KHz.
An earth lead was connected to the rat's skin by means of a small
-crocodile clip. The earth of all the recording equipment was referred
"to a copper water pipe. With these recording conditions, the signal
■to/
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to noise ratio fluctuated between 1:5 and 1:10.
The output from the amplifier was also connected to a Spike
Processor (D.130, Digitimer), and to a tape recorder (Nivico, Victor Co.).
The output of the tape recorder was monitored on an oscilloscope
(Devices 312-, Digitimer). The windows of the spike processor were
also displayed in this oscilloscope which also received the signal from
the amplifier. The spike processor was set to count the number of
spikes crossing the window every 10 sec and its output was connected
to a Potentiometric recorder,(_R.e.20, Servoscribe, Goerz, Electro.).
The action potentials were recorded using a window discriminator whose
output pulses were led to the input of a GEC 2050 computer terminal.
4.4.2 BLOOD PRESSURE RECORDING.
The cannula inserted in the femoral vein was connected to a
transducer (4-327-L221, Bell & Howell Ltd.) and the blood pressure
recorded on a UV recorder (Bell & Howell Ltd.).
4.4.3 STIMULATION.
When a stimulus was delivered, an isolated stimulator (2533,
Devices) was used connected to a current source (NL800 NeuroLog System)
=set up with a maximum scale of 1 mA. The stimulator was triggered with
-a Digitimer (3290, Devices).
■4.4.4 LESIONING
A current provided by a 6 V battery measured with an ammeter
—connected in series, passed through the electrode for a period of time




D-Amphetamine (Smith Kline & French Co„ Ltd.) l.Omg/kg l.Omg/ml
Haloperidol (Serenace, Searle & CO.) O.lmg/kg O.lmg/ml
A tail vein was used for the injection, the skin covering the blood
vessel was pulled away and the injection was done under microscopic
guidance.
C.5 DATA ANALYSIS.
The computer was set to build an interval histogram which was
shown in its display monitor and plotted on paper. The interval
histogram had a time base of 10 or 100 msec for its 256 byte samples,
and counted 1.000 spikes.
When a stimulus was delivered, a post stimulus histogram and an
averaged evoked potential were built with the computer.
The statistical significance of the effect of a drug was estimated
with a Chi Square test (26). The frequencies were calculated by playing
back the recorded experiment into the spike processor, set to count
continuously. The number of spikes during 5 min before the injection
of a drug were considered the expected frequency, and the number of
spikes during the first 5 min after the injection were considered the
observed frequency.
C.6 IDENTIFICATION OF CELLS.
The following 5 criteria aid the choice of cell during the
experiment, but all cells were positively identified after the
xperiment by histological analysis.
1/
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1 - The duration of the spike was used to discard action
potentials recorded from axons. The minimum duration
of a spike to be considered as recorded from a cell
body, was 2 msec.
2 - The firing rate of dopamine cells ranges between 3-10
spikes/sec, (Chapter I Section 3.D)o Only spikes
falling in this range were analysed.
3 - The interval histogram with a mode of 60-250 msec has
been considered also a criteria to identify these
cells (Chapter I, Section 3-D). Therefore, an
interval histogram was always analysed before
continuing with the experiment.
Attempts to identify the dopamine cells by recording antidromic
spikes after the stimulation of the fibres of the medial forebrain
bundle were also made.
Pontamine blue dye was always ejected from the tip of the
electrode at the end of the experiment, in order to identify the
recording area. To eject the dye, 10 pA/5 min (negative current)
were passed between the electrode and the earth lead, (l45).
C.7 HISTOLOGICAL ANALYSIS.
The extension of the lesion was observed using the method
—described in Chapter II, Section C.4.
The mark left by the ejected dye was seen during sectioning on
the microtome with the help of a magnifying glass. The sections were
—collected on glass microscope slides and left in the vapour of
—formaldehyde/
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formaldehyde solution (AnalaR, BDH Chemicals Ltd.) for 24 hr. Then
the staining of the tissue was carried out as previously described
(Chapter II, Section B.4.l).
c..7JL fluorescence microscopy.
The fluorescence of dopamine cells and of the pontamine blue dye,
was observed in some occasions, to determine the recording site.
At the end of the experiment the rats were perfused through the
ascending aorta with 150 ml of an ice-cold solution containing 2/ (w/v)
glyoxylic acid monohydrate and 0.5/ (w/v) paraformaldehyde plus 40g
magnesium sulphate at pH 4-5, (l90). The rat brain was dissected out
and prepared for fluorescence microscopy according to the method
described by Marsden and Kerkut( l96)i piece of tissue 2.5 mm
thick, containing the substantia nigra was frozen in iso-pentane
(BDH, Chemicals Ltd.), cooled to the temperature of liquid nitrogen,
and stored in liquid nitrogen not more than 2 weeks. The tissue was
then freeze-dried, treated with paraformaldehyde vapour, embedded in
paraffin in vacuo and sectioned. The paraformaldehyde vapour
treatment was performed at 80' C for 1 hr using paraformaldehyde (5g/l)
equilibrated at 69.2/ relative humidity. The sections were mounted in
Entellan (Merck) and examined and photographed using a fluorescence
microscope, (Carl Zeiss).
In a few occasions the animals were not previously perfused in
which cases the brain was dissected and prepared for fluorescence
immediately after killing the animals.
d. results.
d.l histology.
The localization of the recording area was done for every animal,
—and/
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and only those showing a dye spot in the substantia nigra pars compacta,
as illustrated in Pig. 15-16 were considered as successfully recorded
from this area.
The fluorescence microscopy did not give successful results every
time and since it is a time consuming procedure, only 4 rats were
finally analysed with this technique, an example of the dye spot around
the fluorescent dopamine cells is given in Pig. 17- It was confirmed
(l90) that perfusion with glyoxylic acid offers an improved
visualization of dopamine neurons, (Pig. 18) compared with the
fluorescence observed when the animal was not perfused, (Pig. 17).
D.2 CONTROL GROUP.
This group was composed of 4 rats with no previous treatment,
lifter amphetamine the firing rate of dopamine cells decreased
significantly in all of them, (Pig- 19). To one animal, haloperidol
iias given approximately 30 min after the amphetamine injection and the
firing rate was significantly increased compared against the firing
rate before and after the injection of amphetamine. When
amphetamine was administered after haloperidol, it did not alter the
discharge of the cell, (Pig. 19)°
Lg» 15 Dye ejected from the recording electrode localized
in the SUBSTANTIA NIGRA PARS COMPACTA. Staining:
Kluver and Barrera Technique, (Section C.7).
Calibration mark: Top = 5Qum, Lower: lOQum.
?ig. 16 Dye ejected from the recording electrode localized in
the SUBSTANTIA NIGRA PARS COMPACTA. Staining: Kluver
and Barrera Technique (Section C.7). Calibration
Mark: Top = 5Qum, Lower: lOQum.
ig. 17 Dye spot in the SUBSTANTIA NIGBA PABS COMPACTA, after
treatment for fluorescence microscopy, (Section C.7.l).
Calibration Mark: 50)m.
ig. 18 Fluorescence of dopamine cells after perfusion with
Glyoxylic Acid, (Section C.7.l).









^■ig. 19 Recording of the firing rate of a cell in the SUBSTANTIA NIGRA
PARS COMPACTA IN CONTROL ANIMALS, (Section D.2)'.
Right Corner: Recording site, (arrow)plotted on a diagram
reproduced from the Konig and Klippel Atlas of
the rat brain,. (174).
Left Corner: Spike reproduced from a photograph taken during
the recording.
Lower Trace: Firing rate of the cell and the effect of:
A = Amphetamine (lmg/Kg) and H = Haloperidol,
(0.1 mg/Kg), administered intravenously.
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Spikes recorded, from an area outside the substantia nigra did not
alter the firing rate after the administration of amphetamine. An
example is shown in Pig. 20.
In two control rats, the blood pressure was recorded simultaneously
to the activity of the cell, in both cases there was no relation between
the firing rate and the blood pressure..
One of the criteria for the identification of dopamine cells
mentioned in Section C.6, was the analysis of an interval histogram.
Examples of typical interval histograms of dopamine cells are shown in
Fig. 21.
Stimulation electrodes were implanted during the recording
experiment in the fibres leaving the substantia nigra through the
medial forebrain bundle, in order to identify the cells by their
antidromic spikes. The electrode was implanted either during the
acute experiment or at least two weeks before the experiment. The
chronic implantation was done with the purpose of testing the animals
for intracranial self stimulation, reported to occur with stimulation
of these fibres, (75)»
Of the 20 animals stimulated in the medial forebrain bundle, in
only 5 antidromic spikes were recorded. Three of these spikes
collided with spontaneous spikes at 4.0, 4.6, and 5.1 msec respectively
therefore probably recorded from cells whose fibres have.a conduction
-velocity of 0.2 m/sec which agrees with the conduction velocity
calculated for these fibres of the nigro-striatal pathway, (Chapter I,
Section 3.B). Only one cell lasted long enough to study the effect
—>f drugs, (Section D.3.l). The other two spikes antidromically
Iriven were probably recorded from axons, since their duration was less
;han 2.0 msec and had a latency of 1.0 msec.
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D.3 EFFECT OF LESICKS IN THE STRIATO-NIGRAL PATHWAY.
D.3.1 MEDIAL LESIONS. '
Cells recorded from 6 rats with a lesion in the ventro-medial
area of the crus cerebri, decreased the firing rate significantly after
amphetamine and increased significantly after haloperidol. The
recording from two of these animals is shown in Pig. 22.
Another rat with a chronic stimulating electrode in the medial
forebrain bundle and a ventro-medial lesion of the crus cerebri, had
a cell antidromically driven, (Section D.2) in this case, amphetamine
produced a decrease in the firing rate statistically significant and
haloperidol reversed its effect. Amphetamine administered after
haloperidol did not have any effect, (Fig. 23).
D.3.2 COMPLETE LESIONS.
Two rats with all the crus cerebri destroyed also showed a
significant reduction in the firing rate after the administration of
amphetamine, (Fig. 24).
D.3.3 ACUTE LESIONS.
Three rats form this group. One rat was lesioned 2 hours before
the recording. In this case the firing rate of the cell was decreased
significantly after amphetamine and increased significantly after
—laloperidol, (Fig. 25).
In two rats it was possible to hold the cell during the lesioning
—Df the striato-nigral pathway. In both cases amphetamine administration
lad a significant depressing effect on the frequency of discharge of the
—jell. In one case, haloperidol injected during the recovery of the
imphetamine effect, produced a further significant increase of the
tiring rate (Fig. 25).
D.4 EFFECT OF THE LESIONS IN OTHER ABEAS.
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D.4.1 LESION OF SUBTHALAMIC NUCLEUS AFP ZONA INCERTA.
One rat that did not display turning behaviour, (Section, C.j)
was recorded from the substantia nigra pars compacta. In this case,
the firing rate of the cell was also significantly decreased after
amphetamine.
The histological analysis indicated that this animal had a
lesion extending to the subthalamic nucleus including the zona
incerta and Forel's fields, (Fig. 26).
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^ig. 20 Effect of amphetamine (a) administration on a cell
recorded outside the substantia nigra, (Section D.7)-
—Fig. 21 Interval Histograms obtained from dopamine cells.
(Sections, C.6 and D.2).
Vertical Axis: Number of spikes,
Horizontal Axis: Time in milliseconds.
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~~i'ig.22 Effect of A LESION IN THE VENTRO-MEDIAL AREA of the crus cerebri,
in the response of a dopamine cell to the administration of dings,
Section D.3.l).
Right Corner: Lesioned area (black) and recording site (arrow)
. plotted on drawings from the Koning and Klippel
atlas of the rat brain, (174).
Left Corner: Spike reproduced from a photograph taken during the
recording.
Lower Trace: Firing rate of the cell and the effect of: A =
Amphetamine (lmg/Kg) and H=Haloperidol (o.lmg/Kg),
administered intravenously.
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"fig. 23 Effect of a lesion in the ventro-medial area of the
crus cerebri on the response of an antidromically
driven dopamine cell to the administration of drugs,
(Section D„9)•
Top Trace: Cummulative record during intracranial
self stimulation, with an electrode



















*?ig. 24 Effect of a COMPLETE LESION of the crus cerebri,
(Section D.3.2) in the response of a dopamine cell














Fig. 26 Effect of a CONTROL LESION above the crus cerebri
in the response of a dopamine cell to the intravenous
administration of Amphetamine (a), (l.O mg/Kg), (Section D.4.l).
Details: Fig. 22.
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D.4.2 PARTIAL LESIONS OF THE SUBSTANTIA NIGRA.
In two occasions the electrode aiming for the crus cerebri was
placed too far back, damaging part of the zona compacta and reticularis
of the substantia nigra, (Fig. 27.) In both occasions the rats
turned more than 100 times/30min.
In one case, neither amphetamine nor haloperidol had a significant
effect on the firing rate. In the other, only after two injections of
amphetamine, making a total dose of 2 mg/Xg, a significant decrease in
the firing rate was observed. Haloperidol administered afterwards did
not have a significant effect, (Fig. 28).
To investigate in more detail the consequence of a partial lesion
of the substantia nigra pars compacta, injections of 6-OHDA were performed.
D.5 EFFECT OF PARTIAL LESIONS OF THE SUBSTANTIA NIGRA WITH 6-OHDA.
Two rats were successfully partially lesioned. One rat had 23.3$
decrease in the concentration of dopamine on the lesioned side, compared
to the unlesioned side. In this case, during the recording of the
—remaining dopamine cells, amphetamine administration did not decrease
the firing rate of the cells, but produced a non-significant increase.
—The other rat only had 12.4$ decrease in the concentration of dopamine
—in the striatum of the lesioned side compared to the intact side. In
■this case only after a second injection of amphetamine, increasing the
■total dose to 2 mg/Xg, a significant decrease in the firing rate was
—)bserved, but this response only lasted for approximately 150 sec.
^!he injection of haloperidol changed the firing pattern of the cell,
—>ut over all the difference was not statistically significant, (Fig.29).
Lesion including part of the zona compacta and zona
reticulata of the substantia nigra, and the dye spot




—fig. 28 Effect of a PARTIAL ELECTROYTIC LESION of the
SUBSTANTIA NIGRA'on the response of a dopamine




-^ig. 29 Effect of a PARTIAL LESION OF IOPAMINE CELLS WITH
6-OHDA on the response of the remaining dopamine cells
to the intravenous administration of drugs, (Section D.6)<»
Details: Fig. 22.
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D.6 KAINIC ACID LESIONS IN THE STRIATUM.
Six rats were injected with kainic acid in the striatum, but
only 5 recovered from the adipsia and aphagia produced by the lesion,
(Chapter Iv, Section E). The other 3 died during the first 48 h after
the operation. During the recording of cells in the substantia nigra,
the administration of amphetamine, produced a significant decrease in
the firing rate. In one occasion because the cell died approximately
15 min after the injection, 2 h later, the effect of another injection
was studied on another cell. As previously, amphetamine produced a
significant decrease in the firing rate of the cell, (Fig. 30). In
all cases the administration of haloperidol produced a significant
increase in the discharge and blocked the effect of a subsequent
injection of amphetamine, (Fig. 30-31).
The histological analysis showed that the lesions included most
of the striatum and extended to part of the globus pallidum and the
thalamic nuclei, (Fig. 30-31).
D.7 ELECTRICAL STIMULATION OF THE MEDIAL FOREBRAIN BUNDLE.
In nine cells recorded from the substantia nigra pars compacta as
indicated by the histological analysis, but not antidromically driven,
the effect of the stimulation was studied. A positive-negative
■potential was averaged with the computer on which a post-stimulus
"histogram was built up simultaneously. The positive wave was accompanied
■by inhibition of the firing rate which lasted for 6.6 msec, (- 2«3).
The positive peak had a latency of 5.8 msec, (- 1.0) and the latency
—of the negative peak was 13.2 msec, (- 1.9), (Fig. 32).
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Fig. 30 Destruction of cells in the STRIATUM with KAINIC ACID and its
effect on the response of a dopamine cell to the intravenous
administration of drugs, (Section D.6).
Top trace: Effect of an injection of A=Amphetamine,
(l.Omg/Kg), on the firing rate of the cell.
Lower trace: Effect of Amphetamine (a) and Haloperidol (h),
on another cell recorded in the same animal 2 h
after the first administration of amphetamine.
Details: Fig. 22.
Fig„ 31 Destruction of cells in the STRIATUM with KAINIC ACID
and its effects on the response of a dopamine cell to
the intravenous administration of drugs, (Section Do6)
Details: Figo 22»
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Fig. 32 Response to electrical stimulation with an electrode
implanted in the medial forebrain bundle, (Section D.9).
Average Field Potential (top trace) and Post Stimulus
Histogram (lower trace) taken simultaneously, (100 sweeps).
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E. DISCUSSION..
E.l WHAT IS THE ORIGIN OF THE INHIBITION OF THE FIRING RATE AND THE
POSITIVE-NEGATIVE FIELD POTENTIAL"EVOKED "IN THE SUBSTANTIA NIGRA
BY STIMULATION IN THE MEDIAL FOREBRAIN BUNDLE?
A field potential has heen recorded in the substantia nigra of rats
after stimulation in the striatum, (88). It is believed to be the
result of inhibition followed by excitation in the cells, produced by
the activity of the striato-nigral pathway. The stimulating current
of an electrode in the medial forebrain bundle could spread to fibres
of the crus cerebri giving ride to the same response. However, the
animals reported in this experiment had a lesion in the crus cerebri
which makes this interpretation difficult to sustain. Moreover as
demonstrated in the previous Chapter, the striato-nigral pathway does
not affect the metabolism of dopamine cells (Section D.4 and E.7) giving
evidence against those studies suggesting that the striato-nigral pathway
exerts an inhibitory action on these cells. Anatomical evidence is
also in agreement with the postulation that this pathway does not
control dopamine cells. It has been indicated that the striato-nigral
pathway does not end in cells of the substantia nigra pars compacta,
but in the pars reticulata, (Chapter I, Sections l.A and l.C).
The nature of the inhibition observed in the substantia nigra after
stimulation in the striatum must be studied carefully. As already
mentioned in Chapter I, Section 3-D most of these reports do not
differentiate between the pars compacta and the pars reticulata of the
substantia nigra, and it may very well be that the inhibition taken as
being produced in the substantia nigra pars compacta is produced in the
pars reticulata by activity of the striato-nigral pathway ending in
this/
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this area but having nothing to do with the dopamine cells. A study-
differentiating between these areas, has reported inhibition in the
substantia nigra pars reticulata in 95$ of the cases, (88) supporting
this idea, that it is in the pars reticulata where the inhibition
occurs in most cases.
If there is an inhibition observed in the substantia nigra pars
compacta after stimulation of the striatum, it is probably mediated
by other pathways than the striato-nigral one.
The inhibition reported here (Section D.10) could be produced
by antidromic stimulation of dopamine fibres which could lead to
lateral inhibition by axon collaterals. An argument in favour of
this suggestion comes from the difficulty in obtaining antidromically
driven cells in the substantia nigra pars compacta (300 and Section
D.9.l). Studies on the steps in the production of spikes carried
out in motoneurons have shown that when an impulse is generated in a
motoneurone there are 3 distinctive components in the rising phase
which have been attributed to the successive invasion of different
regions in the neuron, (67, 68). This analysis was done mainly
studying the effects of the soma membrane potential on the form of an
—antidromic action potential produced by the stimulation of the ventral
—roots. The M spike is believed to represent activity in the myelinated
regibn of the axon, the IS spike, is believed to represent the activity
—of the initial segment, and the SD spike, the activity in the soma and
—dendrites recorded as a full-sized action potential. Blockage between
"the IS and SD spikes has been reported after hyperpolarizing the membrane
^potential, (67, 68, 112). It could be possible to postulate that
—stimulation of the medial forebrain bundle is inducing dopamine release
sither/
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either from dendrites or axon collaterals into neighbouring cells
producing in them a hyperpolarization with the subsequent dissociation
between IS and SD components. Recently it has been reported that most
cells in the substantia nigra pars compacta show a blockage of the SD
spikes, and only the IS spike is recorded making its visualization
difficult, (l39). This agrees with the idea of an arrangement of
cells in the substantia nigra where lateral inhibition can be produced
by dendrites or axon collaterals.
It is important to investigate this suggestion further and study
the effects of the blockage of dopamine receptors (e.g. by haloperidol)
in the antidromic activity and in the inhibition observed in substantia
nigra after stimulation with an electrode implanted in the medial
forebrain bundle.
Another alternative that must be considered in the production of
this field potential and inhibition of the firing rate after
stimulation of the medial forebrain bundle is the possibility of exciting
cells in the lateral hypothalamus exerting an inhibitory action on
dopamine cells. There are reports suggesting the presence of cells in
the medial forebrain bundle "path neurons", projecting to the substantia
nigra pars compacta, (l4). However the anatomical results need to be
taken cautiously, since there is no evidence so far that the axons
terminate in the substantia nigra, and it is also possible that damage
of the fibres around the injection site is the responsible for the
results observed.
The origin of the inhibition of the firing rate and the field
potential that accompanies it, is therefore not clear. The activity of
the striato-nigral pathway is ruled out, leaving as alternatives the
activity/
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activity of inhibitory cells in the medial forebrain bundle or the
production of lateral inhibition by antidromic stimulation of dopamine
fibres.
E.2 DOES THE STRIATO-HTGRAL PATHWAY MEDIATE THE RESPOUSE OF DOPAMINE
CELLS TO AMPHETAMINE?' '
It was described in Chapter II, that lesions in the ventro-lateral
area of the crus cerebri produce the biggest decrease in GAD activity
in the substantia nigra. It was also argued that according to
anatomical studies, the lesions damaged the striato-nigral and pallido-
nigral pathways. The results presented in this Chapter show that
lesions in this area do not alter the firing rate of dopamine cells and
do not abolish the effect of amphetamine or haloperidol on their firing
rate. To eliminate the possibility of remaining fibres travelling
in the crus cerebri responsible for the results observed, the whole
crus cerebri was lesioned and again the response to drugs was not
impaired. The same results were observed with acute lesions and with
lesions of cells in the striatum with kainic acid. This indicates
that the fibres of the striato-nigral pathway do not mediate the
response of dopamine cells to amphetamine, as sustained by the feedback
hypothesis, (Chapter I, Section 3.2). There has been a controversy
about the effects of amphetamine in the activity of dopamine cells as
mentioned in detail in Chapter I, Section 3.E. The results of this
experiment point out that amphetamine decreases the firing rate of
dopamine cells in the substantia nigra and that its effect is not
mediated by the activity of the striato-nigral pathway.
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Fig. 33 Schematic representation of dopamine cells in the
substantia nigra. A: Lateral Inhibition, B: Partial
Lesion, (Section E-2l).
E.2.1 POSSIBLE ALTERNATIVES.
Since the lesion of the crus cerebri blocks the participation from
the striatum and globus pallidum, the effect of amphetamine could be
mediated directly by the drugs inside the substantia nigra or in another
structure sending efferents to it. Afferents have been reported from
the nucleus accumbens, dorsal raphe nucleus, cortex, habenula and
hypothalamus, (43, 272), any of these structures could be affected by
amphetamine/
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amphetamine resulting in an inhibition of cells in the substantia nigra.
However, since dopamine release occurs in the substantia nigra after
amphetamine, (Chapter I, Section 2.D) and these cells are inhibited by
their own transmitter, (Chapter I, Section E.3), it can be proposed
that the response to amphetamine is mediated inside the nucleus. A
way of eliminating the participation of other structures and at the
same time testing the possibility of an effect locally mediated is
through the direct application of amphetamine, into the substantia nigra.
This experiment (l29) is reported (Chapter I, Section 3.F) and indicates
that amphetamine decreases the firing rate of dopamine cells even when
directly administered.
It could be proposed that after the administration of amphetamine
dendrites or axon collaterals are releasing dopamine and that this is
inhibiting their discharge, (Fig«33A). This suggestion is supported
by the results of partial lesions of the substantia nigra reported
in Sections D.4.2 and D.6. In these cases amphetamine did not inhibit
the cells presumably because the neighbouring cells responsible for the
inhibition were missing, (Fig.33, B). It also seems likely that
■previous reports, (l30, 42) of lesions which abolish the effect of
—amphetamine could all have been effective because of the same
■phenomenon.
■E.3 RELEVANCE OF THE EXPERIMENT.
The relevance of the experiments reported in this Chapter lies in
"the demonstration that the striato-nigral pathway does not exert any
^influence in the activity of nigral cells as proposed by the feedback
lypothesis. According to this hypothesis this pathway exerts an
—Inhibitory/
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inhibitory influence on dopamine cells, (Chapter I, Section 3). This
suggestion was supported by the activity of substantia nigra cells after
stimulation of the striatum, however as it has been discussed the evidence
that in fact the cells were from the pars compacta is very poor, the
histological analysis is not shown in many occasions (305, 103, 108)
and no criteria to differentiate between cells in one area and the other
were applied (88, 204, 114, 113).
Further support to the feedback hypothesis came from experiments
indicating that the firing rate of dopamine cells was not affected after
systemic administration of amphetamine if the fibres of the striato-
nigral pathway were damaged either by a hemisection (40) or a lesion
of the crus cerebri (42) immediately before the recording. This was
taken as evidence to say that amphetamine was acting in the terminals
of dopamine fibres in the striatum releasing dopamine there which in
turn activated the striato-nigral pathway to produce inhibition of
dopamine cell bodies, (39, 132, Chapter I, Section E.3.2).
The experiment reported here show that a lesion of the crus cerebri
does not alter the response of the cell to amphetamine and supports the
experiments showing an inhibition of dopamine cells after administration
of amphetamine, (129, 130, Chapter I, Section 3-F).
The only case when amphetamine did not inhibit the firing rate of
—cell was when a partial lesion of the substantia nigra was made,
■—(Sections D.,4.2 and D.5). It is important to mention that the
—^experiments reported elsewhere involving acute lesions, (297, 42)
—rhich gave evidence in favour of the feedback hypothesis, do not
■eport any histological analysis, therefore making it difficult to
mow if the lack of effect by amphetamine was given a similar partial
esion/
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lesion of substantia nigral cells as the reported, here. In fact the
only experiment which mentions histological results, (ljo), reports
that their lesion extended to the substantia nigra. Therefore it can
be concluded, by the experiment reported in this Chapter, that it is
not the lesion of the striato-nigral pathway the one that affects the
response to amphetamine, but a lesion of substantia nigral cells,
which probably affects a system of lateral inhibition.
SUMMARY.
I - Stimulation of fibres in the medial forebrain bundle inhibited the
firing rate of dopamine cells and evoked a positive-negative field
potential. Stimulation of this area produced antidromic spikes in 5
animals of the 17 tested.
II - The firing rate of dopamine cell decreased significantly after the
intravenous administration of amphetamine in the following groups of
rats:
A - Control.
B - Chronically lesioned in: striatum, ventro-medial area of the
crus cerebri and the whole crus
cerebri.
C - Acutely lesioned in the ventro-medial area of the crus cerebri.
Haloperidol reversed the response to amphetamine and blocked the
effect of a subsequent administration of amphetamine, in these groups.
Ill- The following lesions were successful in abolishing the effect




A - Partial electrolytic lesions of the substantia nigra.
B - Partial lesions of dopamine cells with 6-OHDA.
It is concluded that the striato-nigral pathway does not mediate
the decrease in the firing rate of dopamine cells observed after the
intravenous administration of amphetamine.
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BEHAVIOURAL ANALYSIS'OF RATS WITH A LESION
IN THE 5TRIATO-NIGRAL PATHWAY.
A. INTRODUCTION.
A lesion of dopamine cells by intranigral injection of 6-
hydroxydopamine, (6-OHDA), on one side of the brain, produces a
degeneration of the nigro-striatal pathway and causes rats to deviate
their posture towards the lesioned side, (287). In these animals,
dopamine agonists, (e.g. apomorphine or amphetamine) induce a dose
dependent rotation, (237).
The involvement of the nigro-striatal pathway in turning behaviour
has been supported by studies involving electrical stimulation of the
pathway. During continuous electrical stimulation, the rats circle
ds the unstimulated side and this behaviour is blocked by
haloperidol, (l3).
Drug interaction studies confirmed the involvement of dopaminergic
mechanisms in rotation. Inhibition of tyrosine hydroxylase alpha-
methyl-para-tyrosine, (AMP!), blocks the effect of amphetamine, but not
that of apomorphine,(116). Haloperidol antagonizes both amphetamine
and apomorphine effects, (287).
Stimulation of the caudate nucleus of cats, evokes movement of
the head and turning behaviour opposite to the stimulated site, (184).
"The same behaviour pattern can be reproduced with an injection of
dopamine into the nucleus, which also facilitates the response
^produced by electrical stimulation, (66). Haloperidol or AMPT
^■lirectly into the nucleus suppresses the effects of electrical
—stimulation/
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stimulation, suggesting that the activity of the nucleus altered by
changes in dopamine concentration must be involved in the display of
turning behaviour.
Electrolytic lesions in the striatum and globus pallidum in rats
or in the caudate nucleus and interpeduncular nucleus in cats, (73j 79)
produces spontaneous turning towards the lesioned side which is
increased by intraperitoneal injections of L-Dopa, apomorphine or
amphetamine. These drugs presumably act on the dopamine receptors
of cells in the intact side of the brain.
On the other hand, the striatum seems to participate in other
behaviours like passive avoidance, (l09» 240), go no-go tasks, (l72) and
lever pressing, (257), since its lesion or stimulation alters the
performance of the task.
The activity of the striatum is therefore responsable, at least
in part, for the expression of these motor behaviours. Since a major
output from the striatum is through the striato-nigral pathway ending
in the substantia nigra pars reticulata, (Chapter I, Section l.A), and
the results presented in Chapters II and III indicate that it is not
part of a feedback system to control dopamine metabolism, it was
decided to study the participation of the striato-nigral pathway in
tacstor behaviour, in order to clarify its possible function.
In this Chapter changes in paw preference and the amount of
turning behaviour after dopamine agonists were examined after unilateral
electrolytic lesions in the ventro-medial area of the crus cerebri. The
results presented, indicate that the lesions induce a dose dependent
turning towards the lesioned side, decreases the number of turns of a
6-OHDA lesioned animal by 75.5^ and reverses the preference of the
paw/
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paw used for lever pressing, after a lesion contralateral to the
preferred paw. A possible cicrcuit involved in the generation of these
motor behaviours is discussed.
B. PROCEDURE.
There were 3 groups of rats with lesions in the striato-nigral
pathway:
1 - The animals were lesioned, allowed to recover for a week and
tested for turning behaviour..
2 - The rats were kept in reverse day light conditions and received
JO min sessions of behavioural training in a Skinner box, every
day. Once they learned to press a lever to obtain food, their
paw preference was observed during 5 sessions. Then the rats
were lesioned on the contralateral side to the preferred paw,
allowed to recover for a week and tested for lever pressing for
another 5 sessions. Then they were tested for turning behaviour.
3 - The animals received first a unilateral injection of 6-OHDA into
the substantia nigra on one side of the brain, were allowed to
recover for a week and tested for turning behaviour. Then
lesioned again, this time in the ventro-medial area of the
crus cerebri ipsilateral to the previous lesion, allowed to recover
for a week and re-tested for turning behaviour.
Once the behavioural analysis was done, the rats were sacrificed,
;he brain removed for dissection and the biochemical determinations
.nd the histological analysis performed.
METHODS.
The procedure'for stereotaxic surgery, electrolytic lesions and
ost/
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post-operative observations has been described in Chapter II, Sections
C.l, C.l.l and C.,2. For the lesions in the ventro-media area of the
crus cerebri the co-ordinates used were the same as described in
Chapter II, Section C.1,1,
When a sham operation was performed, the animal was anaesthetized
and placed in the stereotaxic frame, the skull was exposed and a hole
was bured in the same place as the lesioned rats. Then the skin
was sutured and the animal was allowed to recover as the lesioned
animals. For the 6-OHDA injections, the co-ordinates used were the
same as described in Chapter III, Section Co2, but since this time a
complete lesion was desired the concentration of 6-OHDA was 2.0 mg/ml;
the volume injected was 4°0 ul.
The procedure for the biochemical determinations of GAD activity
and dopamine concentrations have been described in Chapter II, Section
C.3.5 and C.3.2 respectively.
C.l BEHAYIOXJRAL OBSERYATIOHS.
The animals were housed in groups of 3 per cage and kept in a
cycle of 12 hours reverse day light conditions.
C.l.l TURNING BEHAVIOUR.
The test was carried out in a spherically shaped plastic bowl of
390 sq. cm. The number of complete circles was counted by observation
during 30 min. The counting started 1 min after the injection of drugs.
Any other behaviour was also noted.
C.1.2 LEVER PRESSING.
The animals were deprived of food for 48 hr before the first day
of training, thereafter were fed once a day after the training session
allowing/
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allowing food ad libitum for 1 hr„
The first training session lasted for 45 min, during which the
association lever press-food was established. Then the sessions
lasted 30 min. The paw preference was determined observing every




For crus cerebri lesioned animals:
D-Amphetamine 2 mg/kg 2 mg/ml
Apomorphine 2 mg/kg 2 mg/ml
For 6-OHDA lesioned animals:
Apomorphine 0.2 mg/kg 0.2 mg/ml
All drugs were administered intraperitoneally.
D. RESULTS.
D.l HISTOLOGICAL ANALYSIS.
The rats that turned consistently towards the lesioned side more
than 100 times/30 min were found to have a lesion in the ventro-medial
area of the crus cerebri similar to the one illustrated in Chapter II,
Fig. 7.
The animals which did not display turning behaviour, had lesions
in other places around the crus cerebri like the hippocampus, amygdala,
zona incerta and Forel's fields, (Chapter II, Section D.l.l).
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D.2 TURNING BEHAVIOUR.
When the animals were injected with amphetamine or apomorphine the
posture which by general examination did not differ from control rats,
deviated towards the lesioned side. The tail curved towards the
concave torax and the rat walked in closed circles. Sniffing occurred
and there was little grooming activity. Turning started approximately
3 min after the injection of the drugs and lasted for approximately
30 min after apomorphine and 1 hr after amphetamine administration.
Both drugs induced turning towards the lesioned side.
Six rats with a lesion in the ventro-medial area of the crus cerebri
turned 192.5 times/30 min (- 77.4) after amphetamine administration.
Ten rats with a similar lesion turned 184.6 times/30 min (- 73.4) after
apomorphine administration, (Fig. 34).
When the extent of the lesion was compared to the number of turns
after the apomorphine administration (Chapter II, Fig. 10), it was
observed that rats with lateral lesions turned a smaller number of
times than rats which had the whole crus cerebri destroyed, although
the difference was not statistically significant.
A dose-response curve to apomorphine was constructed with 7 rats,
(Fig. 35)t which shows that turning is dose dependent.
D.,3 PAW PREFERENCE.
The preferred paw was determined for each rat before the lesion.
Two rats pressed more times with the right paw and the other 4 with the
left. After a lesion contralateral to the preferred paw all rats
changed their preference and started to use more the extremity
ipsilateral to the lesioned side. The control animal kept using the
same/
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same paw after a sham operation, (Table XI and Fig. 36).
The side on which the lesion changed effectively the paw
preference was determined on a trial group of 5 rats lesioned in the
left side of the brain independently of their side preference. Onljr
two rats with a lesion contralateral to the preferred paw changed
their preference.
The histological analysis showed that all these rats had a lesion
in the ventro-medial area of the crus cerebri, although not all of the
same magnitude. This was confirmed by the biochemical analysis which
showed that GAD activity was decreased in the substantia nigra
ipsilateral to the lesioned side, in a range from 16.5^ to 53.7^.
The concentration of dopamine in the striatum of the lesioned side did
not differ significantly from its concentration on the unlesioned side,
(Table XII).
D.4 6-OHDA PLUS CRIJS CEREBRI LESIONS.
The number of turns after a crus cerebri lesion in a 6-OHDA
injected animal was significantly reduced compared to the number of
turns after the 6-OHDA lesion alone, (Table XIIl). The biochemical
analysis showed that dopamine in the striaturn ipsilateral to the
6-OHDA injection, was significantly reduced, and GAD activity was also
significantly reduced in the substantia nigra of the same side,
(Table XIII, and Fig. 37).
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Fig.. 34 Turning behaviour inchiced. after amphetamine
(2mg/kg) and apomorphine (2mg/kg)towards
the lesioned side.
Representative lesion (arrow) plotted on a
diagram from the Koning and Klippel atlas of
the rat brain (174)-
Bars = standard deviation of the mean (Section D.2)
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Fig. 55 Dose response curve to apomorphine, in rats
with lesions in the ventro-medial area of the
crus cerebri.





Mean of the difference of lever presses (preferred - non preferred paw)
in 5 sessions.
PREFERRED PAW EXPERIMENTAL GROUP CONTROL
Right ' X 5.4 16.4
S.E.M. 1.9 2.1
BEFORE LESION
Left X 68.4 42.8 40.8 69.8
S.E.M. 14.1 12.2 12.0 16.5
Right X 39.8 69.6 25.6
S.E.M. 30-7 10.1 10.6
AFTER LESION
Left X 100.4 58.2 151.0
S.E.M. 14.1 4.1 6.7


















9.701 8.133 10.986 9-739 11.095 10.780
9.635 8.886 9.600 8.506 9.750 9.802
503.2 428.5 342.3 431.7 526.5 587.2
602.0 588.3 652.1 932.7 691.3 518.4
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Fig.36 Top graphs: Paw preference during 5 sessions, plotted for
each rat before and after a lesion in the striato-
nigral pathway.
Lower graph: Percentage decrease in GAD activity compared to the

















6-OHDA PLUS CRUS CEREBRI LESIONS
NUMBER OP TURNS
AFTER
6-OHDA PLUS DA GAD
6-OHDA CRUS CEREBRI
LESION LESION STRIATUM NIGRA
L C L C
365 29 0.117 10.500 384.1 1015.1
261 24 0.051 5.269 302.2 674.7
246 89 0.063 9.495 169.0 263.2
272 22 0.150 7.513 136.6 188.3
310 237 1.507 5.438 390.5 483.0
325 127 0.113 8.730 335.5 521.4
267 9 0.149 9.694 241.2 261.0
127 2 8.917 8.882 244.4 277.4
98 34 0.164 8.867 95.4 201.0
104 9 6.847 8.930 597.3 824.6
237..5 58.2 1.012 8.331 299.0 461.5













Mean number of turns induced after apomorphine
(0.2 mg/kg) in 6-OHDA lesioned rats, before
and after a lesion in the striato-nigral pathway.
Percentage decrease in dopamine in the striatum
.(Str) and in GAD activity in the substantia
nigra (SN), compared to the unlesioned side.
= difference statistically significant.
TV
(Section D.4)




The turning reported, here after a lesion in the ventro-medial area
of the crus cerebri, was towards the lesioned side independently of the
drug, amphetamine or apomorphine. It can be proposed that these
dopamine agonists act on the side where the striatal output to the
substantia nigra is intact. Amphetamine induces a dose dependent
rotation towards the substantia nigra lesioned side in a 6-OHDA
injected animal, (44). It has been proposed that it acts presynaptically
releasing dopamine on the intact side and this by an unknown effect in
striatal cells causes turning behaviour. Apomorphine induces turning
towards the unlesioned side, that is, opposite to the turning induced
by amphetamine. It is believed that this dopamine agonist reaches
postsynaptic receptors on both sides of the brain, but exerts a
strongest effect on the denervated side, probably due to the development
of postsynaptic supersensitivity, (285).
The mechanism by which turning is produced, surprisingly has
remained a puzzle since turning behaviour was first studied, (5)-
Since rot-ation in a 6-OHDA lesioned animal is induced by dopamine
agonists and blocked by dopamine antagonists, (e.g. haloperidol), it
has been used as a technique for testing the efficacy of new drugs,
(70, 17, 116), although it is not even clear why the animals display
such behaviour.
The experiments presented here give a step towards the under¬
standing of this motor behaviour. The lesion of the striato-nigral
pathway considerably reduces the number of turns to apomorphine after
a 6-OHDA lesion in the substantia nigra, (Section D.4). This points
out that the striato-nigral pathway serves as an output involved in
—turning/
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turning behaviour. A recent paper, (l97) has reported similar findings
in 6-OHDA lesioned animals. Lesions which effectively decreased the
number of turns after apomorphine were localized in the striatum,
globus pallidum or in the crus cerebri where the striato-nigral
pathway runs. Therefore this also indicates that the lesions are
affecting a part of the chain involved in turning behaviour.
Apart from the motor alterations in humans in which the striatum
and the substantia nigra participate, (e.g. Parkinson's Disease (l47,
132) and Hungtington's Disease, (289, 30)), the ventrolateral
thalectoiny, has been used for the relief of tremor and rigidity in
patients suffering from Parkinson's Disease, (250). After lesions in
the ventrolateral nucleus of the thalamus, language and/or speech
deficits are commonly observed in the patients, (250, 80). In monkeys
it has been reported that a lesion in the ventro-lateral nucleus of the
thalamus, produces moderate motor deficits during ballistically initiated
■flexion movements and dysmetria of the hind limbs contralateral to the
lesion side, (243). These results point out that thalamic nuclei as
^rell as the striatum and the substantia nigra, may be involved in a
—single circuit responsible for the motor alterations observed.
It has been reported that cells in the zona reticulata of the
substantia nigra, which are inhibited from the caudate are also
intidromically driven from the ventro-lateral and ventro-medial nucleus
if the thalamus, (83). It has also been reported that stimulation in
he substantia nigra pars reticulata produces an inhibition of cells
—n these thalamic nuclei. In 32/6 of the recorded neurons, the
—nhibition was observed in cells activated by cerebellar stimulation
—nd antidromically driven after cortical stimulation, (84). This,
—ogether/
together with the anatomical reports indicating connections between the
substantia nigra pars reticulata to the thalamus, (251, 56) and from
there to the sensory-motor cortex, (63, 271, 82), provides evidence Tor
the postulation of a circuit involved in the production of turning
behaviour, (Fig. 38).
It can be suggested that manipulation of the concentration of
dopamine in the striatum, will change the concentration of GABA in the
substantia nigra pars reticulata which in turn will affect the nigro-
thalamic input producing a change in excitability of pyramidal cells of
the sensory-motor cortex, by means of the thalamo-cortical fibres.
According to this, the motor cortex would be necessary for the turning
behaviour to occur. In fact, it has been reported that cats and rats
—after the removal of their contralateral sensori-motor cortex, fail
to show turning behaviour, either spontaneously or induced by drugs,
previously observed after striatal lesion, (78, 79).
The reason why an animal with a lesion in the striatum or the crus
cerebri shows turning behaviour towards the lesioned side after
—ipomorphine or amphetamine could be because these drugs are increasing
■■the activity of the striato-nigral pathway of the intact side,
.ncreasing the concentration of GABA in the substantia nigra and
.nducing turning opposite to the side having an increased amount of
—}ABA. In agreement with this, it has been observed that the injection
f GABA agonists, (e.g. muscimol and baclofen) into the substantia
igra induces rotation opposite to the injected side, (260, 228), and
^pomorphine increases the turnover of GABA in the substantia nigra,(235).
imilarly, an increase in the amount of GABA in the substantia nigra by
—ocal injection of ethanolamine-O-sulphate an inhibitor of GABA
Lutamate transaminase, induces turning behaviour opposite to the
ljected side, (176, 294).
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ig. 38 Schematic representation of a possible circuit involved
in turning behaviour. C = sensory-motor cortex;
S = striatum; n = substantia nigra; s = spinal cord;
<Q> = pyramidal cells.T = thalamic nuclei.
Lesions in the substantia nigra pars reticulata induce turning
jhaviour after apomorphine in the same direction as lesions in the
;riato-nigral pathway (ChapterIII, Section D.4.2 and 87, 228). This
in be explained if it is considered that both lesions are blocking the
isponse induced by apomorphine on that side, so that only the cells of
-e/
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the thalamic nuclei on the intact side are being excited.
It is relevant to mention that as reported in Chapter II,
Section D.3.1, rats with a lesion produced by kainic a.cid injection
into the striatum, globus pallidum or ventro-lateral and reticular
nuclei of the thalamus, also showed rotation towards the lesioned side.
The fact that the rat with a thalamic lesion turned 192 times/30 min,
strengthens the suggestion that this structure is involved in turning
behaviour.
In order to test the circuit proposed it is necessary to study,
amongother things, the effects of the manipulation of GABA in the
substantia nigra on the activity of the ventral nuclei of the thalamus
as well as the activity of the pyramidal cells of the sensory-motor
cortex.
Other motor alterations observed after a lesion of the substantia
nigra, the striatum or the striate-nigral pathway, are probably affecting
the same circuit. An example was given here with the changes in paw
preference observed after contralateral lesions, to the preferred paw,
in the striato-nigral pathway. Initially, the rats show a preference
for a paw possibly because they have a natural assymetry in the
concentration of dopamine in the striatum and in the concentration of
GABA in the substantia nigra, which alters the excitability of cells in
the ventro-lateral and ventro-medi&l nucleus of the thalamus and in
turn the excitability of pyramidal cells of the sensory-motor cortex
facilitating the use of one paw. This is certainly vague and imprecise,
and research has to be done to establish if this is plausible. So far,
it has been reported that normal rats also rotate consistently towards
—one side when given apomorphine, amphetamine or L-Dopa (l5l). The
contents/
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contents of dopamine of the left and right striatum were found to differ
by 10-13$ in ordinary conditions and by 25/® following a maximal dose of
amphetamine> (20 mg/kg IP); the rats tended to turn opposite to the
side with the highest level of dopamine, (122) . Similarly, normal
rats exhibit side preferences in a T-rnaze which is enhanced by
amphetamine and coincide with the side of the brain containing the
lowest concentration of dopamine in the striatum, that is the
animal turned opposite to the substantia nigra containing the highest
concentration of dopamine, (30?). Changes in paw preference have
already been reported. Stimulation of the striatum on the same side
to the preferred paw causes a reversal of the side preference, (308)
and the same effect is observed after a lesion of the striatum
contralateral to the preferred paw, (257).
The adipsia and aphagia induced by lesions in the substantia nigra
with 6-OHDA injection (283, 288) was not observed in animals with
lesions of the striato-nigral pathway, although it was observed after
the kainic acid injection into the striatum and globus pallidum,
(Chapter II, Section D.3.l). It would be interesting to see if this
alteration is also seen after bilateral lesions of the striato-nigral
pathway, since unilateral lesions, even with 6-OHDA are less severe,
(288). After unilateral lesions of the striato-nigral pathway
difficulty in swallowing and frequent choking was observed when the
animal was eating. This could be one of the possible reasons why the
sham operated rat pressed a higher number of times than lesioned rats,
in the post-operative test, (Section D.3., Pig. 36). A motor alteration
—and difficulty in swallowing may account for the adipsia and aphagia
—observed after 6-OHDA lesions, although a sensory impariment has also
—been/
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"been suggested, (286)» Electrophysiological data from the substantia
nigra in conscious monkeys emphazise their role in motor behaviour.
Cells in the substantia nigra mainly increased their firing rate while
the animal was moving the mouth, protruding the lips, moving the inferior
maxilar or feeding, independently of the flavour of the invested food,
(210). These observations also suggest that the adipsia and aphagia
observed in animals after 6-OHDA injections into the substantia nigra
may be due to a motor disability rather than an impairment in the
sensory input or motivation.
The results presented in this Chapter illustrated the possibility
of an alternative function for the striato-nigral pathway. Rather
than serving for a feedback to the dopamine cells of the substantia nigra,
it seems to provide a way of connecting the dopamine system with the
motor areas.
E. SUMMARY
An electrolytic lesion in the striato-nigral pathway:
I - Induced turning behaviour towards the lesioned side after
intraperitoneal injections of apomorphine or amphetamine. This
response was dose-dependent.
[I - Significantly reduced the number of turns induced after apomorphine
in animals with 6-OHDA lesions in the substantia nigra.
.II - Changed the preference of the paw used to press a lever in a




The experiments presented here have the relevance of demonstrating
with the use of a small and localized lesion in the striato-nigral
pathway, that cells in the striatum do rot control the metabolism of
dopaminergic cell bodies in the substantia nigra.
As has already been discussed in Chapter I, there were doubts
about the existence of this feedback system. Several laboratories
working on the hypothesis from different angles arrived to the same
conclusion: there must be alternative mechanisms of control of dopamine
metabolism which will explain the effects of antipsychotic drugs,
(256, 282, 120, 130). The alternative explanation of presynaptic
control of dopamine release in the terminals of dopaminergic fibres
within the striatum has been proposed, (Chapter I, Section 2, B.2.3).
Also presynaptic control by means of gabaminergic and cholinergic
neurons in the striatum was postulated, (Chapter I, Section 2.C.l).
Here, it was observed that a lesion in the striato-nigral pathway
do not impair the ability of nigral cells to alter their turnover of
dopamine after haloperidol or apomorphine, (Chapter II, Section D.4).
In every case there was no difference in the concentration of dopamine
or its metabolites HVA and DOPAC between control and lesioned rats.
These experiments were done at a time when release of dopamine was
obtained from the substantia nigra, (73, 119) and when amphetamine was
shown to inhibit dopaminergic cell firing, (2, 39) and induce release
of dopamine from the substantia nigra, (217). This pointed out that
there may be another alternative mechanism in the control of dopamine
release involving dendro-dendritic interaction of axon collaterals from
the dopaminergic cells which synapse on neighbouring cells. The
decrease/
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decrease in firing rate described in Chapter III, in control as well as
lesioned animals, where no feedback was possible, clearly coincides w:th
this hypothesis. The observation that dopaminergic cells when driven
antidromically have a dissociation between the activity in the soma and
dendrites (SD spike) and the spike of the internal segment, (is), (138),
gives evidence that there may be a cell to cell interaction inducing a
hyperpolarization. Haloperidol can speed up cells by disinhibiting
them from their lateral inhibition, blocking the action of dopamine and
increasing the turnover of dopamine in the striatum. By which means
the lateral inhibition takes place is a matter of argument, there is
evidence of dendro-dendritic associations containg vesicles, (139) and
this could be taken as the main evidence to postulate lateral inhibition
■produced by dendritic synapses. However a more recent report indicates
that although there are dendro-dendritic appositions, there are no
■membrane especializations to indicate that synapses is occurring;
membrane attachments, dense projections, vesicles or membrane
^thickenings were not observed between dendrites, (73). If this
—evidence is correct, then lateral inhibition must be produced by axon
—jollaterals, but there is no direct evidence that axon collaterals of
dopaminergic cells synapse in near by cells.
Recently it has been observed that while there is an increase in
Lopamine release in the striatum due to sensory stimulation (e.g.
iressure in the skin, or light in an eye) or stimulation of the dentate
r fastigial cerebellar nuclei, there is a decrease in dopamine release
—n the substantia nigra, (220, 216). It could be proposed that the
—ncrease in dopamine release in the striatum is due to activation of
igro-striatal fibres whereas the decrease in dopamine release observed
-V
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in the substantia nigra is due to the hyperpolarization induced by the
cell to cell interaction in the substantia nigra. It would be
interesting to record from dopaminergic cells after sensory or
cerebellar stimulation in order to see if the cells are activated and
then inhibited probably as a consequence of the proposed
hyperpolarization.
Alternatives to the feedback system favouring the striatum or the
substantia nigra as the site for control of dopamine metabolism, are not
mutually exclusive, and since only one alternative does not explain
all the evidence available for both structures, the regulation of
dopamine metabolism and the effects of antipsychotic drugs, could either
be mediated within each structure by any of the alternative mechanisms
proposed or by an unknown biochemical process. The exclusive control
of dopamine metabolism in the cell bodies cannot explain for instance
the increase in TOH activity in the striatum after an interruption of
the nigro-striatal fibres, or the increase in dopamine overflow after
haloperidol administration in in-vitro studies, (Chapter I, Section 3.2).
On the other hand, alternative explanations taking the striatum as the
only site of control, cannot explain the decrease in firing rate
observed after amphetamine in dopaminergic cells in the substantia
nigra, after lesions in the striato-nigral pathway, (Chapter III).
There are other alternatives that must be considered before
disregarding the possibility of a feedback mediated by a chain of
—aeurons. For instance, lesions of the striato-nigral pathway do not
■■Interrupt all the routes along which the striatum might influence the
—substantia nigra. And afferents to the substantia nigra from other
mclei might be involved as well. Autoradiographic studies, (282,43)
.ndicate/
181.
indicate that the tail of the striatum sends fibres to the lateral
portion of the substantia nigra pars reticulata and lateral areas of
the substantia nigra pars compacta. However, since dopamine and GABA
is found predominantly in the body of the striatum, (280, 146), whereas
the tail contains mainly serotonin, (28l), it is tempting to think that
the pathway most likely involved for the postulated feedback should be
the one from the body of the striatum interrupted by the ventro-medial
lesions of the crus cerebri. In any case, the participation cf this
part of the striatum is also excluded, since lateral lesions of the
crus cerebri interrupting this pathway, did not affect the metabolism
of dopamine or the response of nigral cells to amphetamine or haloperidol,
(Chapter II, Section D.4.1 and Chapter III, Section D.3.2).
The nucleus accumbens, the raphe nucleus, the habenula, the
hypothalamus and the parietal, temporal and insular cortex seem to send
afferents to the substantia nigra, (43, 272). Consistent anatomical
results are obtained from the nucleus accumbens and the dorsal raphe,
but so far there is no evidence of these nuclei participating in the
control of dopamine metabolism in the striatum and substantia nigra.
Stimulation of the medial rraphe nucleus produces an inhibition in 56^
of the cells tested, in the substantia nigra pars compacta, (89).
Lesions of the medial raphe nucleus decrease the concentration cf
serotonin in the substantia nigra and increase the concentration of
dopamine in the striatum, (89). This evidence has been taken as
support to postulate that a mechanism which could affect dopamine
metabolism of substantia nigral cells could be mediated by serotonin
—containing fibres ending in the substantia nigra probably inhibiting
—interneurons. This hypothesis proposes that a decrease in serotonin
—in/
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in the substantia nigra would produce a disinhibition of inhibitory
interneurons which synapse on dopaminergic cells and as a result the
firing rate of dopaminergic cells would decrease and the concentration
of dopamine increase due to less dopamine utilization in the striatum,
(89). It has been shown that dopamine agonists increase the release
of serotonin in the rat brain measured by the levels of 5-hydroxyindo-
lacetic acid (248). It would be interesting to study the effects of
dopamine agonists and antagonists on dopamine turnover after a lesion in
the medial raphe nucleus. If this nucleus is modulating dopamine
metabolism in the way proposed by the feedback hypothesis, the
alteration in dopamine turnover produced by these drugs should be
greatly reduced after the lesion.
The lesions of the whole crus cerebri described in Chapter II
(Table III) or hemisections between the striatum and the substantia
nigra reported elsewhere (200), do not produce more than 70?o decrease
in the concentration of GABA or in GAD activity in the substantia
nigra of the lesioned side. This means that the other 3C$ of the
total concentration of GABA observed in the substantia nigra comes
from another source behind the substantia nigra or is contained within
the nucleus in GABA interneurons. As it has been just described, an
inhibitory interneurone has been proposed to mediate the effects of
serotonin on dopamine cells, (89), this interneurone could be a GABA
containing one. However, other places like the fastigial and the
dentate nucleus of the cerebellum have been suggested to be likely
candidates to send afferents to the substantia nigra, as a result of
biochemical evidence, but there is no direct anatomical evidence, (220).
The role that this J>Ofo of the total concentration of GABA plays in the
control/
183.
control of dopamine metabolism remains to be established.
Recently the existence of another nigro-striatal pathway apart
from the dopamine containing one has been revived in an electrophysio¬
logical report. It has been found that cells from the substantia nigra
pars compacta as well as from the pars reticulata show antidromic
spikes to stimulation of the striatum. The fibres from the
substantia nigra par compacta appear, as already reported, to be slowly
conducting (0.3 - 1.0 m/sec) while the fibres from the pars reticulata
have a faster conduction velocity (l.9 - 10 m/sec). The fibres leaving
the substantia nigra pars reticulata seem to follow the same course
as the dopamine containing ones, since antidromic activity could also
be eroked stimulating the medial forebrain bundle, (85). The
participation of these fibres in the metabolism of dopamine has not
been studied. Although the cells giving rise to the fast nigro-
striatal pathway lie within the pars reticulata, it is not know if the
striato-nigral pathway establishes contact with them. Injections of
colchicine, a drug that blocks axonal transport, into the globus
pallidum and the striatum produces a build up of acetylcholinesterase
within axons following a similar course to the one described for the
dopamine containing pathway. This has been taken as evidence for a
_possible acetylcholine containing pathway from the substantia nigra to
the striatum, (46). However there is always the possibility that the
^acetylcholinesterase observed is contained in the dopaminergic cells.
™[t is also possible that the antidromic activity recorded in this second
ligro-striatal pathway is the result of activation of nigro-cortical
'ibres travelling along the striatum. In fact, a nigro-cortical
pathway has been described (l5)> which could be activated in its way
V
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to the cortex. The existence as well as the possible participation of
this pathway in striatal function need, to be confirmed.
It is interesting to note that a similar "feedback" regulation
in the turnover of serotonin has been observed. Stimulation of
serotoninergic receptors by lysergic acid diethylamide, (LDS), (7) and
some hallucinogenic phenyl ethylamines, (lO) decrease the turnover
of serotonin in the brain and spinal cord of rats measured by the levels
of serotonin after the inhibition of tryptophan hydroxylase. In
contrast the administration of serotoninergic receptor blockers,
(e.g. methysergide, methergoline) induce an increase of synthesis and
turnover of serotonin in rats, (266). A feedback loop formed by a
chain of neurons as in the dopaminergic system has been postulated in
order to explain the results, (7). However, no anatomical evidence
exists of a feedback loop of the kind postulated for the dopamine system
in nuclei containing serotonin like the raphe nuclei. It is very
interesting that as in the case of in vitro studies of dopamine release,
the "feedback" mechanisms are still operating in brain slices for the
release of labelled serotonin induced by electrical field stimulation,
(35). Thus LSD (receptor agonist) and methiothepin (antagonist),
added to the incubating medium, exert opposite effects on the efflux of
serotonin. These results suggest that other mechanism than a feedback
loop is involved in the regulation of transmitter release in the
serotoninergic as well as in the dopaminergic neurons.
According to the feedback hypothesis a decrease in the concentration
of GABA should impair the ability of nigral cells to respond to dopamine
■-agonists and antagonists, since this response is supposed to be
*nediated by GABA fibres ending in dopaminergic cell bodies in the
—substantia/
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substantia nigra. Apart from the evidence already discussed in
Chapter I, Section A.2 and D.l.l and Chapter II, Section E.5 about
the GABA-dopaaine relation, turning behaviour has been used as an
estimate of this relation. An increase in the content of GABA in the
substantia nigra after a local injection of ethanolamine-O-sulphate, an
inhibitor of GABA glutamate transminase, induces turning behaviour
contralateral to the injected side, and stereotyped sniffing and
biting which are intensified by systemic amphetamine administration.
This has been taken as evidence to suggest that an increase in GAEA
levels in the substantia nigra, results in increased functional
activity of the dopaminergic containing nigro-striatal pathway (l76).
However, these same results can be explained with the circuit described
in Chapter IV, Section E, as the result of an increased activity of
cells in the substantia nigra pars reticulata, sending afferents to
thalamic nuclei, and from there to the sensory-motor cortex. Evidence
in favour of this suggestion and against a GABA-dopanine relation, has
also been obtained using turning behaviour as an estimate. Unilateral
injections of the GABA agonist muscimol into substantia nigra, induced
turning contralateral to the injected side even after pretreatment
with dopamine antagonist haloperidol, (294) • It would be interesting
to investigate the effects of 6-OHDA in the substantia nigra on the
turning induced by an increase in GABA transmission in the substantia
nigra. According to what has been'proposed a lesion of dopaminergic
cells should not affect the turning induced by increased GABA or GABA
agonists into substantia nigra.
The results presented in Chapter III, open the possibility of a
different function for the striato-nigral pathway conveying information
out/
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out of the striatum as part of a circuit involved in the expression of
motor behaviour. There are many reports involving the striatum and
the substantia nigra in learning. For instance, it has been found
that lesions of the striatum impair the recall of a learned task or the
ability to acquire a new one, (86, 188, 240)„ Injections of L-Dopa into
the striatum improve tasks which require the animal to stand still,
such as go no-go situations, (l72). On the other hand electrical
stimulation of the substantia nigra pars compacta during the
acquisition of a passive avoidance task impairs the retention of the
correct response, (258), and bilateral lesions of the substantia nigra
with 6-OHDA, appart from inducing severe akinesia, impair the ability
of rats to learn an underwater maze, (246, 116). As well as the
proposed involvement in learning, stimulation or lesion of these
structures produces alteration in motor performance. For instance,
stimulation of the striatum induces movement of the head and turning
behaviour (269), similarly nigral lesioned animals appart form their
akinetic state, have a correlation between the number of dopamine cells
left intact, and the ability of the animal to swim when forced in an
underwater maze, (245). Since it has been reported that unilateral
lesions,do not produce the significant results observed after bilateral
Lesions, it would be very interesting if animals with bilateral
Lesions of the striato-nigral pathway have similar deficits. Since the
'triato-nigral pathway is probably mediating the output of the striatum
;o thalamus and cortical areas, (Chapter Iv, Section E.) it would be
■xpected to affect behaviour in a similar way than bilateral lesions of
he striatum. Also, if the effect of substantia nigral lesions is due
o the lack of dopamine in the striatum induced by the lesion, bilateral
esions/
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lesions of the striato-nigral pathway should impair behaviour in a
similar way.
Over the past few years progressive evidence of the synthesis,
storage, release and catabolism of dopamine has helped in the under¬
standing of the metabolism of synaptic transmitter and the mode of
action of several drugs. However, neurochemical, pharmacological
and electrophysiological evidence of the dopamine containing cells is
not at all complete. The anatomical and biochemical techniques
developed over the last few years have contributed enormously to the
knowledge of these neurons and their interelations, and more
contributions appear every day. Nevertheless probably all these
processes are much more complicated than the simple logic that we are
trying to apply. If one agrees with Einstein that "God does not play
dice with the universe," the apparent incomplete and chaotic state of
the understanding of neuronal function and its interelations, must
become clearer as knowledge develops. But let's also bear in mind as
Professor Hawkins once pointed out, "God not only plays dice, He
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